KR20220127904A - Agrochemical granular composition for rice seedling box application with reduced damage - Google Patents

Agrochemical granular composition for rice seedling box application with reduced damage Download PDF

Info

Publication number
KR20220127904A
KR20220127904A KR1020227028149A KR20227028149A KR20220127904A KR 20220127904 A KR20220127904 A KR 20220127904A KR 1020227028149 A KR1020227028149 A KR 1020227028149A KR 20227028149 A KR20227028149 A KR 20227028149A KR 20220127904 A KR20220127904 A KR 20220127904A
Authority
KR
South Korea
Prior art keywords
methyl
phenyl
agrochemical
granular composition
chloro
Prior art date
Application number
KR1020227028149A
Other languages
Korean (ko)
Inventor
게이이치로 무카이
요시히로 야마구치
히로무 요시우라
요시타카 사토
사토미 후지와라
리사 난야
Original Assignee
바이엘 크롭사이언스 케이. 케이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이엘 크롭사이언스 케이. 케이. filed Critical 바이엘 크롭사이언스 케이. 케이.
Publication of KR20220127904A publication Critical patent/KR20220127904A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/12Powders or granules
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/713Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with four or more nitrogen atoms as the only ring hetero atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00Fungicides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

[과제] 본 발명은 약해가 경감된 벼 육묘 상자 시용의 농약 입제 조성물을 제공한다.
[해결수단] 상기 조성물은 농약 활성 성분, 알킬나프탈렌술폰산 유도체, 알파화 전분, 스멕타이트 광물을 함유하는 것을 특징으로 하는 벼 육묘 상자 시용의 농약 입제 조성물이다.
[Problem] The present invention provides an agrochemical granular composition for application in a rice seedling box with reduced damage.
[Solutions] The composition is an agrochemical granular composition for rice seedling box application, characterized in that it contains an agrochemical active ingredient, an alkylnaphthalenesulfonic acid derivative, pregelatinized starch, and a smectite mineral.

Description

약해를 경감한 벼 육묘 상자 시용 농약 입제 조성물Agrochemical granular composition for rice seedling box application with reduced damage

본 발명은 약해(藥害)를 경감한 벼 육묘 상자 시용(施用) 농약 입제(粒劑) 조성물 및 그의 제조 방법에 관한 것이다. The present invention relates to an agricultural chemical granular composition for rice seedling box application with reduced damage and a method for producing the same.

농약을 사용할 때는, 에너지 절약·환경 부하의 저감이라는 관점에서, 농약의 사용량 또는 사용 횟수를 감소시키는 것이 바람직하다. 이러한 요구를 받아, 이식 수도(水稻) 재배에서는, 논에 사용하고 있었던 농약을 육묘 상자에 시용(施用)하여, 이식 후에 논에서 그의 효과를 발휘하게 하는 육묘 상자 처리가 이루어지고 있다. 그러나, 유묘에 통상의 입상 농약을 처리하면, 용출 혹은 방출되는 농약 활성 성분 또는 그 밖의 성분에 의해 모종의 생육 지연 혹은 생육 불량과 같은 약해를 일으키는 경우가 있었다. 이 때문에, 육묘 기간의 유약한 묘에 약해를 생기지 않게 하거나 또는 경감하는 육묘 상자 처리제의 개발이 요구되고 있다. When using an agrochemical, it is preferable to reduce the usage-amount or frequency of use of an agrochemical from a viewpoint of energy saving and reduction of environmental load. In response to such a request, in transplantation water cultivation, the pesticide used in the paddy field is applied to the seedling box, and the seedling box treatment in which the effect is exhibited in the paddy field after transplantation is performed. However, when seedlings are treated with ordinary granular pesticides, there are cases in which weak damage such as growth retardation or poor growth of seedlings may be caused by the leached or released pesticide active ingredient or other ingredients. For this reason, development of the seedling box treatment agent which prevents or reduces the damage to the weak seedling of a seedling period is calculated|required.

지금까지, 농약 활성 성분의 용출을 억제하여 육묘 상자에서의 유묘와 농약 활성 성분의 접촉에 의한 약해 저감을 목적으로 한 농약 제제가 보고되어 있다(특허문헌 1, 2, 3). 용출 제어 이외의 방법에서는 특정 물질의 첨가에 의한 유묘 약해 저감을 목적으로 한 농약 제제도 보고되어 있다(특허문헌 4). Until now, there have been reported pesticide formulations for the purpose of suppressing the elution of the agrochemical active ingredient and reducing the damage caused by the contact between the seedlings in the seedling box and the agrochemical active ingredient (Patent Documents 1, 2, 3). In methods other than dissolution control, an agrochemical formulation for the purpose of reducing the damage to seedlings by addition of a specific substance has also been reported (Patent Document 4).

특허문헌 1: 일본 특허공개 2012-111752호 공보Patent Document 1: Japanese Patent Laid-Open No. 2012-111752 특허문헌 2: 일본 특허공표 2012-508713호 공보Patent Document 2: Japanese Patent Publication No. 2012-508713 특허문헌 3: 일본 특허공개 2012-17271호 공보Patent Document 3: Japanese Patent Laid-Open No. 2012-17271 특허문헌 4: 일본 특허공개 2009-221108호 공보Patent Document 4: Japanese Patent Laid-Open No. 2009-221108

본 발명의 목적은, 벼 유묘의 생육 불량 리스크가 높은 농약 활성 성분에 대하여 우수한 약해 경감 효과를 갖는 농약 제제 조성물을 제공하는 것이다. An object of the present invention is to provide an agrochemical preparation composition having an excellent weakening effect against an agrochemical active ingredient having a high risk of poor growth of rice seedlings.

본 발명자들은, 농약 활성 성분, 알킬나프탈렌술폰산 유도체, 알파화 전분, 스멕타이트 광물을 함유하는 벼 육묘 상자 시용 농약 입제 조성물이 우수한 약해 경감 효과를 갖는 것을 알아내어, 본 발명을 완성하기에 이르렀다. The present inventors found that an agricultural chemical granular composition for rice seedling box application containing an agrochemical active ingredient, an alkylnaphthalenesulfonic acid derivative, a pregelatinized starch, and a smectite mineral has an excellent weakening effect, and completed the present invention.

본 발명은 이하의 해결 수단을 제공한다. The present invention provides the following solutions.

[1] 농약 활성 성분, 알킬나프탈렌술폰산 유도체, 알파화 전분, 스멕타이트 광물을 함유하는 것을 특징으로 하는 벼 육묘 상자 시용의 농약 입제 조성물. [1] Agrochemical granular composition for rice seedling box application, characterized by containing an agrochemical active ingredient, an alkylnaphthalenesulfonic acid derivative, pregelatinized starch, and a smectite mineral.

[2] 농약 활성 성분의 함유 비율이 1∼30 중량%인 [1]에 기재한 농약 입제 조성물. [2] The agrochemical granular composition according to [1], wherein the content of the agrochemical active ingredient is 1 to 30% by weight.

[3] 알킬나프탈렌술폰산 유도체의 함유 비율이 0.1∼2.0 중량%인 [1] 또는 [2]에 기재한 농약 입제 조성물. [3] The agrochemical granular composition according to [1] or [2], wherein the content of the alkylnaphthalenesulfonic acid derivative is 0.1 to 2.0% by weight.

[4] 알파화 전분의 함유 비율이 0.1∼10 중량%인 [1]∼[3]의 어느 하나에 기재한 농약 입제 조성물. [4] The agrochemical granular composition according to any one of [1] to [3], wherein the content of pregelatinized starch is 0.1 to 10% by weight.

[5] 스멕타이트 광물이 벤토나이트인 [1]∼[4]의 어느 하나에 기재한 농약 입제 조성물. [5] The agrochemical granular composition according to any one of [1] to [4], wherein the smectite mineral is bentonite.

[6] 스멕타이트 광물의 함유 비율이 1∼50 중량%인 [1]∼[5]의 어느 하나에 기재한 농약 입제 조성물. [6] The agrochemical granular composition according to any one of [1] to [5], wherein the smectite mineral content is 1 to 50% by weight.

본 발명의 농약 입상 조성물은, 벼의 육묘 상자에 시용한 경우에, 농약 활성 성분을 포함하는 성분에 의해서 생기는 약해를 경감할 수 있다. When the agricultural chemical granular composition of this invention is applied to the rice seedling box, the weak damage caused by the component containing an agricultural chemical active ingredient can be reduced.

본 발명은, 농약 활성 성분, 알킬나프탈렌술폰산 유도체, 스멕타이트 광물, 알파화 전분을 함유하는 것을 특징으로 하는 벼 육묘 상자 시용의 농약 입제 조성물을 제공한다. The present invention provides an agrochemical granular composition for rice seedling box application, comprising an agrochemical active ingredient, an alkylnaphthalenesulfonic acid derivative, a smectite mineral, and pregelatinized starch.

본 발명에 따른 농약 활성 성분은, 살충제, 살비제, 살선충제, 살균제, 살세균제, 연체동물 구제제, 미생물제, 유익 생물, 살왕우렁이제, 제초제, 조류 기피제, 식물 강화제, 불임제, 정보 화학 물질 및/또는 식물 성장 조절제를 의미한다. Agrochemical active ingredients according to the present invention are pesticides, acaricides, nematicides, fungicides, bactericides, molluscs control agents, microbes, beneficial organisms, lobster worms, herbicides, algae repellents, plant enhancers, sterilants, information chemicals and/or plant growth regulators.

살충제/살비제/살선충제Insecticide/Acaricide/Necticide

본 명세서에서 「일반명」에 의해서 특정되어 있는 활성 성분은 기지이며, 그리고, 예컨대 「“The Pesticide Manual”, 16th ed., British Crop Protection Council 2012」에 기재되어 있거나, 또는 인터넷 상에서 검색할 수 있다(예컨대, 「http://www.alanwood.net/pesticides」). 그의 분류는 본 특허 출원의 출원 시점에서 적용할 수 있는 「IRAC Mode of Action Classification Scheme」에 기초하고 있다. The active ingredient specified by "generic name" in this specification is known, and is described, for example, in ""The Pesticide Manual", 16th ed., British Crop Protection Council 2012, or can be searched on the Internet. (eg, "http://www.alanwood.net/pesticides"). Its classification is based on "IRAC Mode of Action Classification Scheme" applicable at the time of filing of this patent application.

(1) 아세틸콜린 에스테라아제(AChE) 저해약, 예컨대 (1) acetylcholinesterase (AChE) inhibitors, such as

카바메이트계, 예컨대 알라니카브, 알디카브, 벤디오카브, 벤푸라카브, 부토카르복심, 부톡시카르복심, 칼바릴, 카르보푸란, 카르보설판, 에티오펜카브, 페노부카브, 포메타네이트, 푸라티오카브, 이소프로카브, 메티오카브, 메토밀, 메톨카브, 옥사밀, 피리미카브, 프로폭서, 티오디카브, 티오파녹스, 트리아자메이트, 트리메타카브, XMC 및 크실릴카브; 또는carbamates such as alanikab, aldicarb, bendiocarb, benfuracarb, butocarboxyime, butoxycarboxyime, calvaril, carbofuran, carbosulfan, ethiophencarb, fenobucarb, fometa Nate, furatiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pyrimicarb, propoxer, thiodicarb, thiophanox, triazamate, trimetacarb, XMC and xylyl carb; or

유기 인산에스테르계, 예컨대 아세페이트, 아자메티포스, 아진포스-에틸, 아진포스-메틸, 카두사포스, 클로르에톡시포스, 클로르펜빈포스, 클로르메포스, 클로르피리포스-메틸, 쿠마포스, 시아노포스, 디메톤-S-메틸, 다이아지논, 디클로르보스/DDVP, 디크로토포스, 디메토에이트, 디메틸빈포스, 다이술포톤, EPN, 에티온, 에토프로포스, 팜퍼, 페나미포스, 페니트로티온, 펜티온, 포스티아제이트, 헵테노포스, 이미시아포스, 이소펜포스, O-(메톡시아미노티오포스포릴)살리실산이소프로필, 이속사티온, 말라티온, 메카르밤, 메타미도포스, 메티다티온, 메빈포스, 모노크로토포스, 날레드, 오메토에이트, 옥시디메톤-메틸, 파라티온-메틸, 펜토에이트, 포레이트, 포살론, 포스메트, 포스파미돈, 폭심, 피리미포스-메틸, 프로페노포스, 프로페탐포스, 프로티오포스, 피라클로포스, 피리다펜티온, 퀴날포스, 술포텝, 테부피림포스, 테메포스, 터부포스, 테트라클로르빈포스, 티오메톤, 트리아조포스, 트리클로르폰 및 바미도티온. Organic phosphoric acid esters, such as acetate, azamethifos, azinephos-ethyl, azinephos-methyl, cadusaphos, chlorethoxyphos, chlorfenvinphos, chlormephos, chlorpyrifos-methyl, coumaphos, cia nophos, dimethone-S-methyl, diazinon, dichlorbose/DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfotone, EPN, ethion, etoprophos, pamper, phenamiphos, Penitrothione, penthione, phostiazite, heptenophos, imiciaphos, isopenphos, O-(methoxyaminothiophosphoryl) isopropyl salicylate, isoxathione, malathione, mecarbam, metamido Phos, methidathione, mevinphos, monocrotophos, naled, ometoate, oxydimetone-methyl, parathion-methyl, pentoate, porate, phosalone, fosmet, phosphamidone, poxim, pyrimi phos-methyl, propenophos, proptamphos, prothiophos, pyraclophos, pyridapentione, quinalphos, sulfotep, tebupyrimphos, temephos, terbufos, tetrachlorvinphos, thiomethone, triazophos, trichlorphone and bamidothione.

(2) GABA 제어 염화물 채널 차단약, 예컨대(2) GABA control chloride channel blockers, such as

시클로디엔-유기 염소계, 예컨대 클로르단 및 엔도설판; 또는cyclodiene-organochlorine systems such as chlordan and endosulfan; or

페닐피라졸계(피프롤계), 예컨대 에티프롤 및 피프로닐. phenylpyrazoles (fiprole), such as ethiprole and fipronil.

(3) 나트륨 채널 모듈레이터(modulator), 예컨대(3) sodium channel modulators, such as

피레트로이드계, 예컨대 아크리나트린, 알레트린, d-시스-트랜스 알레트린, d-트랜스 알레트린, 비펜트린, 바이오알레트린, 바이오알레트린, S-시클로펜테닐 이성체, 바이오레스메트린, 시클로프로트린, 시플루트린, 베타-시플루트린, 시할로트린, 람다-시할로트린, 감마-시할로트린, 시페르메트린, 알파-시페르메트린, 베타-시페르메트린, 세타-시페르메트린, 제타-시페르메트린, 시페노트린[(1R)-트랜스 이성체], 델타메트린, 엠펜트린[(EZ)-(1R) 이성체], 에스펜발레레이트, 에토펜프록스, 펜프로파트린, 펜발레레이트, 플루시트리네이트, 플루메트린, 타우-플루발리네이트, 할펜프록스, 이미프로트린, 카데트린, 몬플루오로트린, 페르메트린, 페노트린[(1R)-트랜스 이성체], 프랄레트린, 피레트린류(제충국(pyrethrum)), 레스메트린, 실라플루오펜, 테플루트린, 테트라메트린, 테트라메트린[(1R) 이성체], 트랄로메트린 및 트랜스플루트린; 또는pyrethroids, such as acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin, S-cyclopentenyl isomer, bioresmethrin, Cycloprotrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin Lin, theta-cypermethrin, zeta-cypermethrin, cyfenotrin [(1R)-trans isomer], deltamethrin, empenthrin [(EZ)-(1R) isomer], esfenvalerate , etofenprox, fenpropatrine, fenvalerate, flucithrinate, flumethrine, tau-fluvalinate, halfenprox, imiprotrin, cadetrin, monfluorotrin, permethrin, phenotrin Lin [(1R)-trans isomer], pralethrine, pyrethrins (pyrethrum), resmethrin, silafluorphen, tefluthrin, tetramethrin, tetramethrin [(1R) isomer], tralomethrin and transfluthrin; or

DDT; 또는 메톡시클로르. DDT; or methoxychlor.

(4) 니코틴성 아세틸콜린 수용체(nAChR) 경합적 모듈레이터, 예컨대(4) nicotinic acetylcholine receptor (nAChR) competitive modulators, such as

네오니코티노이드계, 예컨대 아세타미프리드, 클로티아니딘, 디노테푸란, 이미다클로프리드, 니텐피람, 티아클로프리드 및 티아메톡삼; 또는neonicotinoids such as acetamiprid, clothianidine, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam; or

니코틴; 또는nicotine; or

술폭사플로르 또는 플루피라디푸론. sulfoxaflor or flupyradifuron.

(5) 니코틴성 아세틸콜린 수용체(nAChR) 알로스테릭 모듈레이터, 예컨대(5) nicotinic acetylcholine receptor (nAChR) allosteric modulators, such as

스피노신계, 예컨대 스피네토람 및 스피노사드. Spinosyns such as spinetoram and spinosad.

(6) 글루타민산 제어 염화물 채널(GluCl) 알로스테릭 모듈레이터, 예컨대(6) Glutamic Acid Control Chloride Channel (GluCl) allosteric modulators, such as

아베르멕틴계/밀베마이신계, 예컨대 아바멕틴, 에마멕틴 안식향산염, 레피멕틴 및 밀베멕틴. avermectins/milbemycins such as abamectin, emamectin benzoate, lepimectin and milbemectin.

(7) 유충 호르몬 모방 물질, 예컨대(7) juvenile hormone mimicking substances, such as

유충 호르몬 유사체, 예컨대 하이드로프렌, 퀴노프렌 및 메트프렌; 또는juvenile hormone analogues such as hydroprene, quinoprene and metprene; or

페녹시카브; 또는 피리프록시펜. phenoxycarb; or pyriproxyfen.

(8) 다양한 특정되지 않은 (다부위) 저해약, 예컨대(8) various unspecified (multi-site) inhibitors, such as

할로겐화 알킬계, 예컨대 브롬화메틸 및 별도의 할로겐화알킬; 또는halogenated alkyl systems such as methyl bromide and separate alkyl halides; or

클로로피크린; 또는 불화술푸릴; 또는 붕사; 또는 토주석; 또는chloropicrin; or sulfuryl fluoride; or borax; or earth tin; or

이소시안산메틸 생성 물질, 예컨대 다조메트(diazomet) 및 메탐. methyl isocyanate generating substances such as diazomet and metam.

(9) 현음 기관 모듈레이터, 예컨대(9) string organ modulators, such as

피메트로진; 또는 플로니카미드. pymetrozine; or flonicamide.

(10) 진드기 성장 저해약, 예컨대(10) tick growth inhibitors, such as

클로펜테진, 헥시티아족스 및 디플로비다진; 또는clopentezine, hexythiazox and diflovidazine; or

에톡사졸. ethoxazole.

(11) 곤충 중장막의 미생물 디스럽터(disruptor), 예컨대(11) a microbial disruptor of the insect midsera, such as

바실루스 투린기엔시스 아종 이스라엘렌시스(Bacillus thuringiensis subspecies israelensis), 바실루스 스파에리쿠스(Bacillus sphaericus), 바실루스 투린기엔시스 아종 아이자와이(Bacillus thuringiensis subspecies aizawai), 바실루스 투린기엔시스 아종 쿠르스타키(Bacillus thuringiensis subspecies kurstaki), 바실루스 투린기엔시스 아종 테네브리오니스(Bacillus thuringiensis subspecies tenebrionis) 및 Bt 식물 단백질: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1/35Ab1. Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies israelensis, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki , Bacillus thuringiensis subspecies tenebrionis and Bt plant proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry3Bb1/35A

(12) 미토콘드리아 ATP 신타아제의 저해약, 예컨대 ATP , 예컨대(12) inhibitors of mitochondrial ATP synthase, such as ATP, such as

디아펜티우론; 또는diafenthiuron; or

유기 주석 화합물, 예컨대 아조시클로틴, 시헥사틴 및 산화펜부타주석; 또는organotin compounds such as azocyclotin, cyhexatin and phenbutatin oxide; or

프로파자이트; 또는 테트라디폰. propazite; or tetradiphone.

(13) 프로톤 구배를 파괴하는 것에 의한 산화적 인산화의 탈공역제(脫共役劑), 예컨대(13) deconjugation agents of oxidative phosphorylation by disrupting the proton gradient, such as

클로르페나피르, DNOC 및 술플루라미드. Chlorfenapyr, DNOC and sulfuramide.

(14) 니코틴성 아세틸콜린 수용체 채널 차단약, 예컨대(14) nicotinic acetylcholine receptor channel blockers, such as

벤술탑, 카르탑 염산염, 티오시클람 및 티오술탑-나트륨. Bensultap, Cartap Hydrochloride, Thiocyclam and Thiosultap-Sodium.

(15) 키틴 생합성의 저해약(타입 0), 예컨대(15) inhibitors of chitin biosynthesis (type 0), such as

비스트리플루론, 클로르플루아주론, 디플루벤주론, 플루시클록수론, 플루페녹수론, 헥사플루무론, 루페누론, 노발루론, 노비플루무론, 테플루벤주론 및 트리플루무론. Bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, nobiflumuron, teflubenzuron and triflumuron.

(16) 키틴 생합성의 저해약(타입 1), 예컨대(16) inhibitors of chitin biosynthesis (type 1), such as

부프로페진. bupropezin.

(17) 탈피 디스럽터(특히 쌍시목(雙翅目)인 경우), 예컨대(17) Moulting disruptors (especially in the case of bipolar trees), such as

시로마진.Syromazine.

(18) 에크디손 수용체 작동약, 예컨대(18) ecdysone receptor agonists, such as

크로마페노지드, 할로페노지드, 메톡시페노지드 및 테부페노지드. Chromafenozide, halofenozide, methoxyfenozide and tebufenozide.

(19) 옥토파민 수용체 작동약, 예컨대(19) octopamine receptor agonists, such as

아미트라즈. Amitraz.

(20) 미토콘드리아 복합체 III 전자 전달 저해약, 예컨대(20) mitochondrial complex III electron transport inhibitors, such as

히드라메틸논; 또는 아세퀴노실; 또는 플루아크리피림. hydramethylnon; or acequinosyl; or fluacrypyrim.

(21) 미토콘드리아 복합체 I 전자 전달 저해약, 예컨대(21) mitochondrial complex I electron transport inhibitors, such as

METI 살비제, 예컨대 페나자퀸, 펜피록시메이트, 피리미디펜, 피리다벤, 테부펜피라드 및 톨펜피라드; 또는METI acaricides such as fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad; or

로테논(Derris). rotenone (Derris).

(22) 전위 의존성 나트륨 채널 차단약, 예컨대(22) potential dependent sodium channel blockers, such as

인독사카브; 또는 메타플루미존. indoxacarb; or metaflumizone.

(23) 아세틸 CoA 카르복실라아제의 저해약, 예컨대(23) inhibitors of acetyl CoA carboxylase, such as

테토론산 유도체 및 테트라민산 유도체, 예컨대 스피로디클로펜, 스피로메시펜 및 스피로테트라마트. tetoronic acid derivatives and tetramic acid derivatives such as spirodiclofen, spiromesifen and spirotetramat.

(24) 미토콘드리아 복합체 IV 전자 전달 저해약, 예컨대(24) mitochondrial complex IV electron transport inhibitors, such as

포스핀계, 예컨대 인화알루미늄, 인화칼슘, 포스핀 및 인화아연; 또는phosphine-based, such as aluminum phosphide, calcium phosphide, phosphine and zinc phosphide; or

시안화물, 시안화칼슘, 시안화칼륨 및 시안화나트륨. cyanide, calcium cyanide, potassium cyanide and sodium cyanide.

(25) 미토콘드리아 복합체 II 전자 전달 저해약, 예컨대(25) mitochondrial complex II electron transport inhibitors, such as

β-케토니트릴 유도체, 예컨대 시에노피라펜 및 시플푸메토펜 및 카르복사닐리드, 예컨대 피플루부미드. β-ketonitrile derivatives such as cyenopyrafen and ciflfumethophen and carboxanilides such as fiflubumide.

(28) 리아노딘 수용체 모듈레이터, 예컨대(28) ryanodine receptor modulators, such as

디아미드계, 예컨대 클로란트라닐프롤, 시안트라닐프롤, 플루벤디아미드, 테트라닐리프롤(tetraniliprole) 및 테트라클로란트라닐리프롤(tetrachlorantraniliprole). diamides such as chlorantranilprole, cyanthranilprole, flubendiamide, tetraniliprole and tetrachlorantraniliprole.

추가적인 활성 성분, 예컨대 아피도피로펜, 아폭솔라너, 아자디라크틴, 인피르플룩삼, 벤클로티아즈, 벤족시메이트, 비페나제이트, 브로플라닐리드(broflanilide), 브로모프로필레이트, 키노메티오네이트, 클로로프랄레트린(chloroprallethrin), 빙정석(cryolite), 시클라닐리프롤, 시클록사프리드(cycloxaprid), 시할로디아미드(cyhalodiamide), 디클로로메조티아즈(dicloromezotiaz), 디코폴, ε-메토플루트린(epsilon metofluthrin), ε-몸플루트린(epsilon momfluthrin), 플로메토퀸, 플루아자인돌리진(fluazaindolizine), 플루엔술폰, 플루페네림, 플루페녹시스트로빈, 플루피프롤, 플루헥사폰(fluhexafon),플루오피람, 플루랄라너, 플룩사메타마이드, 푸페노지드(fufenozide), 구아디피르(guadipyr), 헵타플루트린, 이미다클로티즈, 이프로디온, κ-비펜트린, κ-테플루트린, 로틸라너(lotilaner), 메페르플루트린, 파이콩딩(paichongding), 피리달릴, 피리플루퀴나존, 피리미노스트로빈, 스피로부디클로펜(spirobudiclofen), 테트라메틸플루트린, 티옥사자펜, 티오플루옥시메이트(thiofluoximate), 트리플루메조피림 및 요오도메탄; 추가로additional active ingredients such as apidopyrrofen, apoxolaner, azadiractin, inpirfluxam, benzlotiaz, benzoximate, bifenazate, broflanilide, bromopropylate, Chinomethionate, chloroprallethrin, cryolite, cyclaniliprol, cycloxaprid, cyhalodiamide, dichloromezotiaz, dicopol, ε -Metofluthrin, epsilon momfluthrin, flumetoquine, fluazaindolizine, fluenesulfone, fluphenerim, fluphenoxystrobin, flufiprole, flu hexafon, fluopyram, fluralaner, fluxametamide, fufenozide, guadipyr, heptafluthrin, imidaclotiz, iprodione, κ-bifenthrin, κ- Tefluthrin, lotilaner, meperfluthrin, paichongding, pyridalyl, pyrifluquinazone, pyriminostrobin, spirobudiclofen, tetramethylflutrin, thioxazafen , thiofluoximate, triflumesopyrim and iodomethane; Add to

바실루스 피르무스(Bacillus firmus)에 기초한 조제물(I-1582, BioNeem, Votivo) 및 이하의 화합물: Preparations based on Bacillus firmus (I-1582, BioNeem, Votivo) and the following compounds:

1-{2-플루오로-4-메틸-5-[(2,2,2-트리플루오로에틸)술피닐]페닐}-3-(트리플루오로메틸)-1H-1,2,4-트리아졸-5-아민(WO 2006/043635 A로부터 기지된 것)(CAS 885026-50-6), {1'-[(2E)-3-(4-클로로페닐)프로프-2-엔-1-일]-5-플루오로스피로[인돌-3,4'-피페리딘]-1(2H)-일}(2-클로로피리딘-4-일)메탄온(WO 2003/106457 A로부터 기지된 것)(CAS 637360-23-7), 2-클로로-N-[2-{1-[(2E)-3-(4-클로로페닐)프로프-2-엔-1-일]피페리딘-4-일}-4-(트리플루오로메틸)페닐]이소니코틴아미드(WO 2006/003494 A로부터 기지된 것)(CAS 872999-66-1), 3-(4-클로로-2,6-디메틸페닐)-4-히드록시-8-메톡시-1,8-디아자스피로[4.5]데크-3-엔-2-온(WO 2010/052161 A로부터 기지된 것)(CAS 1225292-17-0), 3-(4-클로로-2,6-디메틸페닐)-8-메톡시-2-옥소-1,8-디아자스피로[4.5]데크-3-엔-4-일 에틸카보네이트(EP 2647626 B로부터 기지된 것)(CAS-1440516-42-6), 4-(부트-2-인-1-일옥시)-6-(3,5-디메틸피페리딘-1-일)-5-플루오로피리미딘(WO 2004/099160 A로부터 기지된 것)(CAS 792914-58-0), PF1364(JP 2010/018586 A로부터 기지된 것)(CAS Reg. No. 1204776-60-2), N-[(2E)-1-[(6-클로로피리딘-3-일)메틸]피리딘-2(1H)-일리덴]-2,2,2-트리플루오로아세트아미드(WO 2012/029672 A로부터 기지된 것)(CAS 1363400-41-2), (3E)-3-[1-[(6-클로로-3-피리딜)메틸]-2-피리딜리덴]-1,1,1-트리플루오로프로판-2-온(WO 2013/144213 A로부터 기지된 것)(CAS 1461743-15-6), N-[3-(벤질카르바모일)-4-클로로페닐]-1-메틸-3-(펜타플루오로에틸)-4-(트리플루오로메틸)-1H-피라졸-5-카르복사미드(WO 2010/051926 A로부터 기지된 것)(CAS 1226889-14-0), 5-브로모-4-클로로-N-[4-클로로-2-메틸-6-(메틸카르바모일)페닐]-2-(3-클로로-2-피리딜)피라졸-3-카르복사미드(CN 103232431 A로부터 기지된 것)(CAS 1449220-44-3), 4-[5-(3,5-디클로로페닐)-4,5-디히드로-5-(트리플루오로메틸)-3-이소옥사졸릴]-2-메틸-N-(시스-1-옥사이드-3-티에타닐)벤즈아미드, 4-[5-(3,5-디클로로페닐)-4,5-디히드로-5-(트리플루오로메틸)-3-이소옥사졸릴]-2-메틸-N-(트랜스-1-옥사이드-3-티에타닐)벤즈아미드 및 4-[(5S)-5-(3,5-디클로로페닐)-4,5-디히드로-5-(트리플루오로메틸)-3-이소옥사졸릴]-2-메틸-N-(시스-1-옥사이드-3-티에타닐)벤즈아미드(WO 2013/050317 A1로부터 기지된 것)(CAS 1332628-83-7), N-[3-클로로-1-(3-피리디닐)-1H-피라졸-4-일]-N-에틸-3-[(3,3,3-트리플루오로프로필)술피닐]프로판아미드, (+)-N-[3-클로로-1-(3-피리디닐)-1H-피라졸-4-일]-N-에틸-3-[(3,3,3-트리플루오로프로필)술피닐]프로판아미드 및 (-)-N-[3-클로로-1-(3-피리디닐)-1H-피라졸-4-일]-N-에틸-3-[(3,3,3-트리플루오로프로필)술피닐]프로판아미드(WO 2013/162715 A2, WO 2013/162716 A2, US 2014/0213448 A1로부터 기지된 것)(CAS 1477923-37-7), 5-[[(2E)-3-클로로-2-프로펜-1-일]아미노]-1-[2,6-디클로로-4-(트리플루오로메틸)페닐]-4-[(트리플루오로메틸)술피닐]-1H-피라졸-3-카르보니트릴(CN 101337937 A로부터 기지된 것)(CAS 1105672-77-2), 3-브로모-N-[4-클로로-2-메틸-6-[(메틸아미노)티옥소메틸]페닐]-1-(3-클로로-2-피리디닐)-1H-피라졸-5-카르복사미드(Liudaibenjiaxuanan, CN 103109816 A로부터 기지된 것)(CAS 1232543-85-9); N-[4-클로로-2-[[(1,1-디메틸에틸)아미노]카르보닐]-6-메틸페닐]-1-(3-클로로-2-피리디닐)-3-(플루오로메톡시)-1H-피라졸-5-카르복사미드(WO 2012/034403 A1로부터 기지된 것)(CAS 1268277-22-0), N-[2-(5-아미노-1,3,4-티아디아졸-2-일)-4-클로로-6-메틸페닐]-3-브로모-1-(3-클로로-2-피리디닐)-1H-피라졸-5-카르복사미드(WO 2011/085575 A1로부터 기지된 것)(CAS 1233882-22-8), 4-[3-[2,6-디클로로-4-[(3,3-디클로로-2-프로펜-1-일)옥시]페녹시]프로폭시]-2-메톡시-6-(트리플루오로메틸)피리미딘(CN 101337940 A로부터 기재된 것)(CAS 1108184-52-6); (2E)- 및 (2Z)-2-[2-(4-시아노페닐)-1-[3-(트리플루오로메틸)페닐]에틸리덴]-N-[4-(디플루오로메톡시)페닐]히드라진카르복사미드(CN 101715774 A로부터 기지된 것)(CAS 1232543-85-9); 시클로프로판카르복실산 3-(2,2-디클로로에테닐)-2,2-디메틸-4-(1H-벤즈이미다졸-2-일)페닐에스테르(CN 103524422 A로부터 기지된 것)(CAS 1542271-46-4); (4aS)-7-클로로-2,5-디히드로-2-[[(메톡시카르보닐)[4-[(트리플루오로메틸)티오]페닐]아미노]카르보닐]인데노[1,2-e][1,3,4]옥사디아진-4a(3H)-카르복실산메틸에스테르(CN 102391261 A로부터 기지된 것)(CAS 1370358-69-2); 6-데옥시-3-O-에틸-2,4-디-O-메틸-1-[N-[4-[1-[4-(1,1,2,2,2-펜타플루오로에톡시)페닐]-1H-1,2,4-트리아졸-3-일]페닐]카바메이트]-α-L-만노피라노오스(US 2014/0275503 A1로부터 기지된 것)(CAS 1181213-14-8); 8-(2-시클로프로필메톡시-4-트리플루오로메틸페녹시)-3-(6-트리플루오로메틸피리다진-3-일)-3-아자비시클로[3.2.1]옥탄(CAS 1253850-56-4), (8-안티)-8-(2-시클로프로필메톡시-4-트리플루오로메틸페녹시)-3-(6-트리플루오로메틸피리다진-3-일)-3-아자비시클로[3.2.1]옥탄(CAS 933798-27-7), (8-신)-8-(2-시클로프로필메톡시-4-트리플루오로메틸페녹시)-3-(6-트리플루오로메틸피리다진-3-일)-3-아자비시클로[3.2.1]옥탄(WO 2007/040280 A1, WO 2007/040282 A1로부터 기지된 것)(CAS 934001-66-8) 및 N-[3-클로로-1-(3-피리디닐)-1H-피라졸-4-일]-N-에틸-3-[(3,3,3-트리플루오로프로필)티오]프로판아미드(WO 2015/058021 A1, WO 2015/058028 A1로부터 기지된 것)(CAS 1477919-27-9). 1-{2-Fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4- Triazol-5-amine (known from WO 2006/043635 A) (CAS 885026-50-6), {1'-[(2E)-3-(4-chlorophenyl)prop-2-ene- 1-yl]-5-fluorospiro[indole-3,4'-piperidin]-1(2H)-yl}(2-chloropyridin-4-yl)methanone (known from WO 2003/106457 A ) (CAS 637360-23-7), 2-chloro-N-[2-{1-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]piperi Din-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (known from WO 2006/003494 A) (CAS 872999-66-1), 3-(4-chloro-2,6 -dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one (known from WO 2010/052161 A) (CAS 1225292-17 -0), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-yl ethyl carbonate ( known from EP 2647626 B) (CAS-1440516-42-6), 4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)- 5-fluoropyrimidine (known from WO 2004/099160 A) (CAS 792914-58-0), PF1364 (known from JP 2010/018586 A) (CAS Reg. No. 1204776-60-2) , N-[(2E)-1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide (WO 2012/029672 known from A) (CAS 1363400-41-2), (3E)-3-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-1,1,1 -trifluoropropan-2-one (known from WO 2013/144213 A) (CAS 1461743-15-6), N-[3-(benzylcarbamoyl)-4-chlorophenyl]-1-methyl -3-(Pentafluoroethyl)-4-(trifluoromethyl) tyl)-1H-pyrazole-5-carboxamide (known from WO 2010/051926 A) (CAS 1226889-14-0), 5-bromo-4-chloro-N-[4-chloro-2 -Methyl-6-(methylcarbamoyl)phenyl]-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide (known from CN 103232431 A) (CAS 1449220-44-3 ), 4- [5- (3,5-dichlorophenyl) -4,5-dihydro-5- (trifluoromethyl) -3-isoxazolyl] -2-methyl-N- (cis-1- Oxide-3-thietanyl)benzamide, 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl -N-(trans-1-oxide-3-thietanyl)benzamide and 4-[(5S)-5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl )-3-isoxazolyl]-2-methyl-N-(cis-1-oxide-3-thietanyl)benzamide (known from WO 2013/050317 A1) (CAS 1332628-83-7), N -[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]propanamide; (+)-N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl) alcohol Pynyl]propanamide and (-)-N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-tri Fluoropropyl)sulfinyl]propanamide (known from WO 2013/162715 A2, WO 2013/162716 A2, US 2014/0213448 A1) (CAS 1477923-37-7), 5-[[(2E)-3 -Chloro-2-propen-1-yl]amino]-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H- Pyrazole-3-carbonitrile (known from CN 101337937 A) (CAS 1105672-77-2), 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)thioxo methyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (Liudaibenjiax uanan, known from CN 103109816 A) (CAS 1232543-85-9); N-[4-chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy) -1H-pyrazole-5-carboxamide (known from WO 2012/034403 A1) (CAS 1268277-22-0), N-[2-(5-amino-1,3,4-thiadiazole) -2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide from WO 2011/085575 A1 known) (CAS 1233882-22-8), 4-[3-[2,6-dichloro-4-[(3,3-dichloro-2-propen-1-yl)oxy]phenoxy]pro poxy]-2-methoxy-6-(trifluoromethyl)pyrimidine (as described from CN 101337940 A) (CAS 1108184-52-6); (2E)- and (2Z)-2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy) phenyl]hydrazinecarboxamide (known from CN 101715774 A) (CAS 1232543-85-9); Cyclopropanecarboxylic acid 3-(2,2-dichloroethenyl)-2,2-dimethyl-4-(1H-benzimidazol-2-yl)phenyl ester (known from CN 103524422 A) (CAS 1542271 -46-4); (4aS)-7-chloro-2,5-dihydro-2-[[(methoxycarbonyl)[4-[(trifluoromethyl)thio]phenyl]amino]carbonyl]indeno[1,2 -e][1,3,4]oxadiazine-4a(3H)-carboxylic acid methyl ester (known from CN 102391261 A) (CAS 1370358-69-2); 6-deoxy-3-O-ethyl-2,4-di-O-methyl-1-[N-[4-[1-[4-(1,1,2,2,2-pentafluoroe oxy)phenyl]-1H-1,2,4-triazol-3-yl]phenyl]carbamate]-α-L-mannopyranose (known from US 2014/0275503 A1) (CAS 1181213-14 -8); 8-(2-cyclopropylmethoxy-4-trifluoromethylphenoxy)-3-(6-trifluoromethylpyridazin-3-yl)-3-azabicyclo[3.2.1]octane (CAS 1253850 -56-4), (8-anti)-8-(2-cyclopropylmethoxy-4-trifluoromethylphenoxy)-3-(6-trifluoromethylpyridazin-3-yl)-3 -azabicyclo[3.2.1]octane (CAS 933798-27-7), (8-sine)-8-(2-cyclopropylmethoxy-4-trifluoromethylphenoxy)-3-(6-tri Fluoromethylpyridazin-3-yl)-3-azabicyclo[3.2.1]octane (known from WO 2007/040280 A1, WO 2007/040282 A1) (CAS 934001-66-8) and N-[ 3-Chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)thio]propanamide (WO 2015/ 058021 A1, known from WO 2015/058028 A1) (CAS 1477919-27-9).

살균제disinfectant

본 명세서에서 「일반명」에 의해서 특정되어 있는 활성 성분은 기지이며, 그리고, 예컨대 「“Pesticide Manual"(16th Ed., British Crop Protection Council)」에 기재되어 있거나, 또는 인터넷 상에서 검색할 수 있다(예컨대, 「http://www.alanwood.net/pesticides」). The active ingredient specified by the "generic name" in the present specification is known, and, for example, it is described in the "Pesticide Manual" (16th Ed., British Crop Protection Council), or can be searched on the Internet ( For example, "http://www.alanwood.net/pesticides").

클래스 (1)∼(15)에 기재되어 있는 모든 성분은, 이들의 작용기에 기초하여 가능하다면 경우에 따라 적절한 염기 또는 산과 염을 형성할 수 있다. 클래스 (1)∼(15)에 기재되어 있는 모든 살균제 혼합 성분은 경우에 따라 호변 이성체 형태를 포함할 수 있다. All of the components described in classes (1) to (15), based on their functional groups, can form salts with appropriate bases or acids, if possible, if appropriate. All of the disinfectant mixture components described in classes (1) to (15) may optionally contain tautomeric forms.

(1) 에르고스테롤 생합성의 저해약, 예컨대 (1.001) 시프로코나졸, (1.002) 디페노코나졸, (1.003) 에폭시코나졸, (1.004) 펜헥사미드, (1.005) 펜프로피딘, (1.006) 펜프로피모르프, (1.007) 펜피라자민, (1.008) 플루퀸코나졸, (1.009) 플루트리아폴, (1.010) 이마잘릴, (1.011) 황산이마잘릴, (1.012) 이프코나졸, (1.013) 메트코나졸, (1.014) 미클로부타닐, (1.015) 파클로부트라졸, (1.016) 프로클로라즈, (1.017) 프로피코나졸, (1.018) 프로티오코나졸, (1.019) 피리속사졸, (1.020) 스피록사민, (1.021) 테부코나졸, (1.022) 테트라코나졸, (1.023) 트리아디메놀, (1.024) 트리데모르프, (1.025) 트리티코나졸, (1.026) (1R,2S,5S)-5-(4-클로로벤질)-2-(클로로메틸)-2-메틸-1-(1H-1,2,4-트리아졸-1-일메틸)시클로펜탄올, (1.027) (1S,2R,5R)-5-(4-클로로벤질)-2-(클로로메틸)-2-메틸-1-(1H-1,2,4-트리아졸-1-일메틸)시클로펜탄올, (1.028) (2R)-2-(1-클로로시클로프로필)-4-[(1R)-2,2-디클로로시클로프로필]-1-(1H-1,2,4-트리아졸-1-일)부탄-2-올, (1.029) (2R)-2-(1-클로로시클로프로필)-4-[(1S)-2,2-디클로로시클로프로필]-1-(1H-1,2,4-트리아졸-1-일)부탄-2-올, (1.030) (2R)-2-[4-(4-클로로페녹시)-2-(트리플루오로메틸)페닐]-1-(1H-1,2,4-트리아졸-1-일)프로판-2-올, (1.031) (2S)-2-(1-클로로시클로프로필)-4-[(1R)-2,2-디클로로시클로프로필]-1-(1H-1,2,4-트리아졸-1-일)부탄-2-올, (1.032) (2S)-2-(1-클로로시클로프로필)-4-[(1S)-2,2-디클로로시클로프로필]-1-(1H-1,2,4-트리아졸-1-일)부탄-2-올, (1.033) (2S)-2-[4-(4-클로로페녹시)-2-(트리플루오로메틸)페닐]-1-(1H-1,2,4-트리아졸-1-일)프로판-2-올, (1.034) (R)-[3-(4-클로로-2-플루오로페닐)-5-(2,4-디플루오로페닐)-1,2-옥사졸-4-일](피리딘-3-일)메탄올, (1.035) (S)-[3-(4-클로로-2-플루오로페닐)-5-(2,4-디플루오로페닐)-1,2-옥사졸-4-일](피리딘-3-일)메탄올, (1.036) [3-(4-클로로-2-플루오로페닐)-5-(2,4-디플루오로페닐)-1,2-옥사졸-4-일](피리딘-3-일)메탄올, (1.037) 1-({(2R,4S)-2-[2-클로로-4-(4-클로로페녹시)페닐]-4-메틸-1,3-디옥솔란-2-일}메틸)-1H-1,2,4-트리아졸, (1.038) 1-({(2S,4S)-2-[2-클로로-4-(4-클로로페녹시)페닐]-4-메틸-1,3-디옥솔란-2-일}메틸)-1H-1,2,4-트리아졸, (1.039) 1-{[3-(2-클로로페닐)-2-(2,4-디플루오로페닐)옥시란-2-일]메틸}-1H-1,2,4-트리아졸-5-일티오시아네이트, (1.040) 1-{[rel(2R,3R)-3-(2-클로로페닐)-2-(2,4-디플루오로페닐)옥시란-2-일]메틸}-1H-1,2,4-트리아졸-5-일티오시아네이트, (1.041) 1-{[rel(2R,3S)-3-(2-클로로페닐)-2-(2,4-디플루오로페닐)옥시란-2-일]메틸}-1H-1,2,4-트리아졸-5-일티오시아네이트, (1.042) 2-[(2R,4R,5R)-1-(2,4-디클로로페닐)-5-히드록시-2,6,6-트리메틸헵탄-4-일]-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.043) 2-[(2R,4R,5S)-1-(2,4-디클로로페닐)-5-히드록시-2,6,6-트리메틸헵탄-4-일]-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.044) 2-[(2R,4S,5R)-1-(2,4-디클로로페닐)-5-히드록시-2,6,6-트리메틸헵탄-4-일]-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.045) 2-[(2R,4S,5S)-1-(2,4-디클로로페닐)-5-히드록시-2,6,6-트리메틸헵탄-4-일]-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.046) 2-[(2S,4R,5R)-1-(2,4-디클로로페닐)-5-히드록시-2,6,6-트리메틸헵탄-4-일]-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.047) 2-[(2S,4R,5S)-1-(2,4-디클로로페닐)-5-히드록시-2,6,6-트리메틸헵탄-4-일]-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.048) 2-[(2S,4S,5R)-1-(2,4-디클로로페닐)-5-히드록시-2,6,6-트리메틸헵탄-4-일]-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.049) 2-[(2S,4S,5S)-1-(2,4-디클로로페닐)-5-히드록시-2,6,6-트리메틸헵탄-4-일]-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.050) 2-[1-(2,4-디클로로페닐)-5-히드록시-2,6,6-트리메틸헵탄-4-일]-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.051) 2-[2-클로로-4-(2,4-디클로로페녹시)페닐]-1-(1H-1,2,4-트리아졸-1-일)프로판-2-올, (1.052) 2-[2-클로로-4-(4-클로로페녹시)페닐]-1-(1H-1,2,4-트리아졸-1-일)부탄-2-올, (1.053) 2-[4-(4-클로로페녹시)-2-(트리플루오로메틸)페닐]-1-(1H-1,2,4-트리아졸-1-일)부탄-2-올, (1.054) 2-[4-(4-클로로페녹시)-2-(트리플루오로메틸)페닐]-1-(1H-1,2,4-트리아졸-1-일)펜탄-2-올, (1.055) 2-[4-(4-클로로페녹시)-2-(트리플루오로메틸)페닐]-1-(1H-1,2,4-트리아졸-1-일)프로판-2-올, (1.056) 2-{[3-(2-클로로페닐)-2-(2,4-디플루오로페닐)옥시란-2-일]메틸}-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.057) 2-{[rel(2R,3R)-3-(2-클로로페닐)-2-(2,4-디플루오로페닐)옥시란-2-일]메틸}-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.058) 2-{[rel(2R,3S)-3-(2-클로로페닐)-2-(2,4-디플루오로페닐)옥시란-2-일]메틸}-2,4-디히드로-3H-1,2,4-트리아졸-3-티온, (1.059) 5-(4-클로로벤질)-2-(클로로메틸)-2-메틸-1-(1H-1,2,4-트리아졸-1-일메틸)시클로펜탄올, (1.060) 5-(알릴술파닐)-1-{[3-(2-클로로페닐)-2-(2,4-디플루오로페닐)옥시란-2-일]메틸}-1H-1,2,4-트리아졸, (1.061) 5-(알릴술파닐)-1-{[rel(2R,3R)-3-(2-클로로페닐)-2-(2,4-디플루오로페닐)옥시란-2-일]메틸}-1H-1,2,4-트리아졸, (1.062) 5-(알릴술파닐)-1-{[rel(2R,3S)-3-(2-클로로페닐)-2-(2,4-디플루오로페닐)옥시란-2-일]메틸}-1H-1,2,4-트리아졸, (1.063) N'-(2,5-디메틸-4-{[3-(1,1,2,2-테트라플루오로에톡시)페닐]술파닐}페닐)-N-에틸-N-메틸이미드포름아미드, (1.064) N'-(2,5-디메틸-4-{[3-(2,2,2-트리플루오로에톡시)페닐]술파닐}페닐)-N-에틸-N-메틸이미드포름아미드, (1.065) N'-(2,5-디메틸-4-{[3-(2,2,3,3-테트라플루오로프로폭시)페닐]술파닐}페닐)-N-에틸-N-메틸이미드포름아미드, (1.066) N'-(2,5-디메틸-4-{[3-(펜타플루오로에톡시)페닐]술파닐}페닐)-N-에틸-N-메틸이미드포름아미드, (1.067) N'-(2,5-디메틸-4-{3-[(1,1,2,2-테트라플루오로에틸)술파닐]페녹시}페닐)-N-에틸-N-메틸이미드포름아미드, (1.068) N'-(2,5-디메틸-4-{3-[(2,2,2-트리플루오로에틸)술파닐]페녹시}페닐)-N-에틸-N-메틸이미드포름아미드, (1.069) N'-(2,5-디메틸-4-{3-[(2,2,3,3-테트라플루오로프로필)술파닐]페녹시}페닐)-N-에틸-N-메틸이미드포름아미드, (1.070) N'-(2,5-디메틸-4-{3-[(펜타플루오로에틸)술파닐]페녹시}페닐)-N-에틸-N-메틸이미드포름아미드, (1.071) N'-(2,5-디메틸-4-페녹시페닐)-N-에틸-N-메틸이미드포름아미드, (1.072) N'-(4-{[3-(디플루오로메톡시)페닐]술파닐}-2,5-디메틸페닐)-N-에틸-N-메틸이미드포름아미드, (1.073) N'-(4-{3-[(디플루오로메틸)술파닐]페녹시}-2,5-디메틸페닐)-N-에틸-N-메틸이미드포름아미드, (1.074) N'-[5-브로모-6-(2,3-디히드로-1H-인덴-2-일옥시)-2-메틸피리딘-3-일]-N-에틸-N-메틸이미드포름아미드, (1.075) N'-{4-[(4,5-디클로로-1,3-티아졸-2-일)옥시]-2,5-디메틸페닐}-N-에틸-N-메틸이미드포름아미드, (1.076) N'-{5-브로모-6-[(1R)-1-(3,5-디플루오로페닐)에톡시]-2-메틸피리딘-3-일}-N-에틸-N-메틸이미드포름아미드, (1.077) N'-{5-브로모-6-[(1S)-1-(3,5-디플루오로페닐)에톡시]-2-메틸피리딘-3-일}-N-에틸-N-메틸이미드포름아미드, (1.078) N'-{5-브로모-6-[(시스-4-이소프로필시클로헥실)옥시]-2-메틸피리딘-3-일}-N-에틸-N-메틸이미드포름아미드, (1.079) N'-{5-브로모-6-[(트랜스-4-이소프로필시클로헥실)옥시]-2-메틸피리딘-3-일}-N-에틸-N-메틸이미드포름아미드, (1.080) N'-{5-브로모-6-[1-(3,5-디플루오로페닐)에톡시]-2-메틸피리딘-3-일}-N-에틸-N-메틸이미드포름아미드. (1) inhibitors of ergosterol biosynthesis, such as (1.001) ciproconazole, (1.002) difenoconazole, (1.003) epoxyconazole, (1.004) fenhexamid, (1.005) fenpropidine, (1.006) fen Profimorph, (1.007) Fenpyrazamine, (1.008) Fluquinconazole, (1.009) Flutriafol, (1.010) Imazalil, (1.011) Imazalyl sulfate, (1.012) Ifconazole, (1.013) Met Conazole, (1.014) Microbutanil, (1.015) Paclobutrazole, (1.016) Prochloraz, (1.017) Propiconazole, (1.018) Prothioconazole, (1.019) Pyrisoxazole, (1.020) ) spiroxamine, (1.021) tebuconazole, (1.022) tetraconazole, (1.023) triadimenol, (1.024) tridemorph, (1.025) triticonazole, (1.026) (1R,2S,5S) )-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.027) (1S ,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, ( 1.028) (2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl) Butan-2-ol, (1.029) (2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4- Triazol-1-yl)butan-2-ol, (1.030) (2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1 ,2,4-triazol-1-yl)propan-2-ol, (1.031) (2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl] -1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.032) (2S)-2-(1-chlorocyclopropyl)-4-[(1S)-2 ,2-Dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.033) (2S)-2-[4-(4-chlorophene) Noxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.034) (R)-[3-(4) -Chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.035) (S)- [3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) -1,2-oxazol-4-yl] (pyridin-3-yl) methanol, (1.036 ) [3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) -1,2-oxazol-4-yl] (pyridin-3-yl) methanol, ( 1.037) 1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H -1,2,4-triazole, (1.038) 1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3- Dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.039) 1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxy Ran-2-yl]methyl}-1H-1,2,4-triazol-5-ylthiocyanate, (1.040) 1-{[rel(2R,3R)-3-(2-chlorophenyl)- 2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-ylthiocyanate, (1.041) 1-{[rel(2R) ,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-ylthio Cyanate, (1.042) 2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4 -dihydro-3H-1,2,4-triazole-3-thione, (1.043) 2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2 ,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.044) 2-[(2R,4S,5R)-1 -(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione , (1.045) 2-[(2R,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy Cy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.046) 2-[(2S,4R,5R )-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole- 3-Thion, (1.047) 2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2, 4-dihydro-3H-1,2,4-triazole-3-thione, (1.048) 2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy- 2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.049) 2-[(2S,4S,5S)- 1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3- Thione, (1.050) 2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2 ,4-triazole-3-thione, (1.051) 2- [2-chloro-4- (2,4-dichlorophenoxy) phenyl] -1- (1H-1,2,4-triazole-1- yl) propan-2-ol, (1.052) 2- [2-chloro-4- (4-chlorophenoxy) phenyl] -1- (1H-1,2,4-triazol-1-yl) butane- 2-ol, (1.053) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butane -2-ol, (1.054) 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1H-1,2,4-triazol-1-yl) Pentan-2-ol, (1.055) 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1H-1,2,4-triazol-1-yl ) propan-2-ol, (1.056) 2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-di Hydro-3H-1,2,4-triazole-3-thione, (1.057) 2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluoro phenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione; (1.058) 2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-di Hydro-3H-1,2,4-triazole-3-thione, (1.059) 5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4 -Triazol-1-ylmethyl)cyclopentanol, (1.060) 5-(allylsulfanyl)-1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxy Ran-2-yl]methyl}-1H-1,2,4-triazole, (1.061) 5-(allylsulfanyl)-1-{[rel(2R,3R)-3-(2-chlorophenyl) -2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.062) 5-(allylsulfanyl)-1-{[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.063 ) N'-(2,5-dimethyl-4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimideform Amide, (1.064) N'-(2,5-dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methyl is Midformamide, (1.065) N'-(2,5-dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl- N-methylimideformamide, (1.066) N'-(2,5-dimethyl-4-{[3-(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methyl is Midformamide, (1.067) N'-(2,5-dimethyl-4-{3-[(1,1,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl- N-methylimideformamide, (1.068) N'-(2,5-dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)-N- Ethyl-N-methylimideformamide, (1.069) N'-(2,5-dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl )-N-ethyl-N-methylimideformamide, (1.070) N'-(2,5-dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N- Ethyl-N-methylimideformamide, (1.071) N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylimideformamide, (1.072) N'-(4-{[3-(difluoromethoxy)phenyl] Sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimideformamide, (1.073) N'-(4-{3-[(difluoromethyl)sulfanyl]phenoxy}- 2,5-Dimethylphenyl)-N-ethyl-N-methylimideformamide, (1.074) N'-[5-bromo-6-(2,3-dihydro-1H-inden-2-yloxy) )-2-methylpyridin-3-yl]-N-ethyl-N-methylimideformamide, (1.075) N'-{4-[(4,5-dichloro-1,3-thiazole-2- yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimideformamide, (1.076) N'-{5-bromo-6-[(1R)-1-(3,5) -difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimideformamide, (1.077) N'-{5-bromo-6-[(1S) -1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimideformamide, (1.078) N′-{5-bromo -6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimideformamide, (1.079) N'-{5-bromo -6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimideformamide, (1.080) N'-{5-bromo -6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimideformamide.

(2) 복합체 I 또는 복합체 II에 있어서의 호흡쇄의 저해약, 예컨대 (2.001) 벤조빈디플루피르, (2.002) 빅사펜, (2.003) 보스칼리드, (2.004) 카르복신, (2.005) 플루오피람, (2.006) 플루톨라닐, (2.007) 플록사피록사드, (2.008) 푸라메트피르, (2.009) 이소페타미드, (2.010) 이소피라잠(안티-에피머성 에난티오머 1R,4S,9S), (2.011) 이소피라잠(안티-에피머성 에난티오머 1S,4R,9R), (2.012) 이소피라잠(안티-에피머성 라세미 화합물 1RS,4SR,9SR), (2.013) 이소피라잠(신-에피머성 라세미 화합물(1RS,4SR,9RS)과 안티-에피머성 라세미 화합물(1RS,4SR,9SR)의 혼합물), (2.014) 이소피라잠(신-에피머성 에난티오머 1R,4S,9R), (2.015) 이소피라잠(신-에피머성 에난티오머 1S,4R,9S), (2.016) 이소피라잠(신-에피머성 라세미 화합물 1RS,4SR,9RS), (2.017) 펜플루펜, (2.018) 펜티오피라드, (2.019) 피디플루메토펜(pydiflumetofen), (2.020) 피라지플루미드, (2.021) 세닥산, (2.022) 1,3-디메틸-N-(1,1,3-트리메틸-2,3-디히드로-1H-인덴-4-일)-1H-피라졸-4-카르복사미드, (2.023) 1,3-디메틸-N-[(3R)-1,1,3-트리메틸-2,3-디히드로-1H-인덴-4-일]-1H-피라졸-4-카르복사미드, (2.024) 1,3-디메틸-N-[(3S)-1,1,3-트리메틸-2,3-디히드로-1H-인덴-4-일]-1H-피라졸-4-카르복사미드, (2.025) 1-메틸-3-(트리플루오로메틸)-N-[2'-(트리플루오로메틸)비페닐-2-일]-1H-피라졸-4-카르복사미드, (2.026) 2-플루오로-6-(트리플루오로메틸)-N-(1,1,3-트리메틸-2,3-디히드로-1H-인덴-4-일)벤즈아미드, (2.027) 3-(디플루오로메틸)-1-메틸-N-(1,1,3-트리메틸-2,3-디히드로-1H-인덴-4-일)-1H-피라졸-4-카르복사미드, (2.028) 3-(디플루오로메틸)-1-메틸-N-[(3R)-1,1,3-트리메틸-2,3-디히드로-1H-인덴-4-일]-1H-피라졸-4-카르복사미드, (2.029) 3-(디플루오로메틸)-1-메틸-N-[(3S)-1,1,3-트리메틸-2,3-디히드로-1H-인덴-4-일]-1H-피라졸-4-카르복사미드, (2.030) 3-(디플루오로메틸)-N-(7-플루오로-1,1,3-트리메틸-2,3-디히드로-1H-인덴-4-일)-1-메틸-1H-피라졸-4-카르복사미드, (2.031) 3-(디플루오로메틸)-N-[(3R)-7-플루오로-1,1,3-트리메틸-2,3-디히드로-1H-인덴-4-일]-1-메틸-1H-피라졸-4-카르복사미드, (2.032) 3-(디플루오로메틸)-N-[(3S)-7-플루오로-1,1,3-트리메틸-2,3-디히드로-1H-인덴-4-일]-1-메틸-1H-피라졸-4-카르복사미드, (2.033) 5,8-디플루오로-N-[2-(2-플루오로-4-{[4-(트리플루오로메틸)피리딘-2-일]옥시}페닐)에틸]퀴나졸린-4-아민, (2.034) N-(2-시클로펜틸-5-플루오로벤질)-N-시클로프로필-3-(디플루오로메틸)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.035) N-(2-tert-부틸-5-메틸벤질)-N-시클로프로필-3-(디플루오로메틸)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.036) N-(2-tert-부틸벤질)-N-시클로프로필-3-(디플루오로메틸)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.037) N-(5-클로로-2-에틸벤질)-N-시클로프로필-3-(디플루오로메틸)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.038) N-(5-클로로-2-이소프로필벤질)-N-시클로프로필-3-(디플루오로메틸)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.039) N-[(1R,4S)-9-(디클로로메틸렌)-1,2,3,4-테트라히드로-1,4-메타노나프탈렌-5-일]-3-(디플루오로메틸)-1-메틸-1H-피라졸-4-카르복사미드, (2.040) N-[(1S,4R)-9-(디클로로메틸렌)-1,2,3,4-테트라히드로-1,4-메타노나프탈렌-5-일]-3-(디플루오로메틸)-1-메틸-1H-피라졸-4-카르복사미드, (2.041) N-[1-(2,4-디클로로페닐)-1-메톡시프로판-2-일]-3-(디플루오로메틸)-1-메틸-1H-피라졸-4-카르복사미드, (2.042) N-[2-클로로-6-(트리플루오로메틸)벤질]-N-시클로프로필-3-(디플루오로메틸)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.043) N-[3-클로로-2-플루오로-6-(트리플루오로메틸)벤질]-N-시클로프로필-3-(디플루오로메틸)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.044) N-[5-클로로-2-(트리플루오로메틸)벤질]-N-시클로프로필-3-(디플루오로메틸)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.045) N-시클로프로필-3-(디플루오로메틸)-5-플루오로-1-메틸-N-[5-메틸-2-(트리플루오로메틸)벤질]-1H-피라졸-4-카르복사미드, (2.046) N-시클로프로필-3-(디플루오로메틸)-5-플루오로-N-(2-플루오로-6-이소프로필벤질)-1-메틸-1H-피라졸-4-카르복사미드, (2.047) N-시클로프로필-3-(디플루오로메틸)-5-플루오로-N-(2-이소프로필-5-메틸벤질)-1-메틸-1H-피라졸-4-카르복사미드, (2.048) N-시클로프로필-3-(디플루오로메틸)-5-플루오로-N-(2-이소프로필벤질)-1-메틸-1H-피라졸-4-카르보티오아미드, (2.049) N-시클로프로필-3-(디플루오로메틸)-5-플루오로-N-(2-이소프로필벤질)-1-메틸-1H-피라졸-4-카르복사미드, (2.050) N-시클로프로필-3-(디플루오로메틸)-5-플루오로-N-(5-플루오로-2-이소프로필벤질)-1-메틸-1H-피라졸-4-카르복사미드, (2.051) N-시클로프로필-3-(디플루오로메틸)-N-(2-에틸-4,5-디메틸벤질)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.052) N-시클로프로필-3-(디플루오로메틸)-N-(2-에틸-5-플루오로벤질)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.053) N-시클로프로필-3-(디플루오로메틸)-N-(2-에틸-5-메틸벤질)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.054) N-시클로프로필-N-(2-시클로프로필-5-플루오로벤질)-3-(디플루오로메틸)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.055) N-시클로프로필-N-(2-시클로프로필-5-메틸벤질)-3-(디플루오로메틸)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드, (2.056) N-시클로프로필-N-(2-시클로프로필벤질)-3-(디플루오로메틸)-5-플루오로-1-메틸-1H-피라졸-4-카르복사미드. (2) inhibitors of the respiratory chain in complex I or complex II, such as (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.004) carboxycin, (2.005) fluopyram, (2.006) flutolanil, (2.007) floxapyroxad, (2.008) furametpyr, (2.009) isopetamide, (2.010) isopyrazam (anti-epimeric enantiomer 1R,4S,9S), (2.011) isopyrazam (anti-epimeric enantiomer 1S,4R,9R), (2.012) isopyrazam (anti-epimeric racemic compound 1RS,4SR,9SR), (2.013) isopyrazam (sine) -A mixture of an epimeric racemic compound (1RS,4SR,9RS) and an anti-epimeric racemic compound (1RS,4SR,9SR), (2.014) isopyrazam (syn-epimeric enantiomer 1R,4S, 9R), (2.015) isopyrazam (neo-epimeric enantiomer 1S,4R,9S), (2.016) isopyrazam (neo-epimeric racemic compound 1RS,4SR,9RS), (2.017) fenflu fen, (2.018) penthiopyrad, (2.019) pydiflumetofen, (2.020) pyraziflumide, (2.021) cedaxane, (2.022) 1,3-dimethyl-N- (1,1, 3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.023) 1,3-dimethyl-N-[(3R)-1,1 ,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.024) 1,3-dimethyl-N-[(3S)-1, 1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.025) 1-methyl-3-(trifluoromethyl)-N -[2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.026) 2-fluoro-6-(trifluoromethyl)-N-( 1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide, (2.027) 3-(difluoromethyl)-1-methyl-N-(1,1,3 -trimethyl-2,3-dihydro-1H-inden-4-yl)-1H -Pyrazole-4-carboxamide, (2.028) 3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H- inden-4-yl]-1H-pyrazole-4-carboxamide, (2.029) 3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2 ,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.030) 3-(difluoromethyl)-N-(7-fluoro-1,1, 3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide, (2.031) 3-(difluoromethyl)-N-[ (3R)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.032 ) 3-(difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl- 1H-Pyrazole-4-carboxamide, (2.033) 5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl) ]oxy}phenyl)ethyl]quinazolin-4-amine, (2.034) N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro -1-methyl-1H-pyrazole-4-carboxamide, (2.035) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5- Fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.036) N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro -1-methyl-1H-pyrazole-4-carboxamide, (2.037) N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro -1-methyl-1H-pyrazole-4-carboxamide, (2.038) N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro Rho-1-methyl-1H-pyrazole-4-carboxamide, (2.039) N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4 -methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.040) N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1 -Methyl-1H-pyrazole-4-carboxamide, (2.041) N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl) -1-methyl-1H-pyrazole-4-carboxamide, (2.042) N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl) -5-Fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.043) N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclo Propyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.044) N-[5-chloro-2-(trifluoromethyl)benzyl ]-N-Cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.045) N-cyclopropyl-3-(difluoro Methyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide, (2.046) N-cyclopropyl-3 -(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.047) N-cyclopropyl -3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.048) N-cyclo Propyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide, (2.049) N-cyclopropyl- 3-(Difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.050) N-cyclopropyl-3-( Difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.051) N-cyclopropyl-3 -(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.052) N-cyclopropyl -3-(difluoromethyl)-N-(2-ethyl-5-pl Luorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.053) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5) -Methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.054) N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3- (difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.055) N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3 -(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.056) N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(di Fluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide.

(3) 복합체 III에 있어서의 호흡쇄의 저해약, 예컨대 (3.001) 아메톡트라딘, (3.002) 아미설브롬, (3.003) 아족시스트로빈, (3.004) 쿠메톡시스트로빈(coumethoxystrobin), (3.005) 쿠목시스트로빈, (3.006) 시아조파미드, (3.007) 디목시스트로빈, (3.008) 에녹사스트로빈, (3.009) 파목사돈, (3.010) 펜아미돈, (3.011) 플루페녹시스트로빈(flufenoxystrobin), (3.012) 플루옥사스트로빈, (3.013) 크레속심-메틸, (3.014) 메토미노스트로빈, (3.015) 오리사스트로빈, (3.016) 피콕시스트로빈, (3.017) 피라클로스트로빈, (3.018) 피라메토스트로빈, (3.019) 피라옥시스트로빈, (3.020) 트리플록시스트로빈, (3.021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-플루오로-2-페닐비닐]옥시}페닐)에틸리덴]아미노}옥시)메틸]페닐}-2-(메톡시이미노)-N-메틸아세트아미드, (3.022) (2E,3Z)-5-{[1-(4-클로로페닐)-1H-피라졸-3-일]옥시}-2-(메톡시이미노)-N,3-디메틸펜트-3-엔아미드, (3.023) (2R)-2-{2-[(2,5-디메틸페녹시)메틸]페닐}-2-메톡시-N-메틸아세트아미드, (3.024) (2S)-2-{2-[(2,5-디메틸페녹시)메틸]페닐}-2-메톡시-N-메틸아세트아미드, (3.025) (3S,6S,7R,8R)-8-벤질-3-[({3-[(이소부티릴옥시)메톡시]-4-메톡시피리딘-2-일}카르보닐)아미노]-6-메틸-4,9-디옥소-1,5-디옥소난-7-일 2-메틸프로파노에이트, (3.026) 2-{2-[(2,5-디메틸페녹시)메틸]페닐}-2-메톡시-N-메틸아세트아미드, (3.027) N-(3-에틸-3,5,5-트리메틸시클로헥실)-3-포름아미드-2-히드록시벤즈아미드, (3.028) (2E,3Z)-5-{[1-(4-클로로-2-플루오로페닐)-1H-피라졸-3-일]옥시}-2-(메톡시이미노)-N,3-디메틸펜트-3-엔아미드. (3) Respiratory chain inhibitors in Complex III, such as (3.001) amethotradine, (3.002) amisulbrom, (3.003) azoxystrobin, (3.004) coumethoxystrobin, (3.005) ) coumoxystrobin, (3.006) cyazofamide, (3.007) dimoxystrobin, (3.008) enoxastrobin, (3.009) famoxadone, (3.010) phenamidone, (3.011) flufenoxystrobin ), (3.012) fluoxastrobin, (3.013) cresoxime-methyl, (3.014) metomynostrobin, (3.015) orissastrobin, (3.016) picoxastrobin, (3.017) pyraclostrobin, (3.018) ) pyrametostrobin, (3.019) pyraoxystrobin, (3.020) trifloxistrobin, (3.021) (2E)-2-{2-[({[(1E)-1-(3-{[( E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (3.022) (2E,3Z )-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.023) (2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.024) (2S)-2-{2-[(2) ,5-Dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.025) (3S,6S,7R,8R)-8-benzyl-3-[({3-[(iso Butyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl 2-methylpro Panoate, (3.026) 2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.027) N-(3-ethyl-3,5 ,5-Trimethylcyclohexyl)-3-formamide-2-hydroxybenzamide, (3.028) (2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyra zol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide.

(4) 유사 분열 및 세포 분열의 저해약, 예컨대 (4.001) 카르벤다짐, (4.002) 디에토펜카브, (4.003) 에타복삼, (4.004) 플루오피콜리드, (4.005) 펜시쿠론, (4.006) 티아벤다졸, (4.007) 티오파네이트-메틸, (4.008) 족사미드, (4.009) 3-클로로-4-(2,6-디플루오로페닐)-6-메틸-5-페닐피리다진, (4.010) 3-클로로-5-(4-클로로페닐)-4-(2,6-디플루오로페닐)-6-메틸피리다진, (4.011) 3-클로로-5-(6-클로로피리딘-3-일)-6-메틸-4-(2,4,6-트리플루오로페닐)피리다진, (4.012) 4-(2-브로모-4-플루오로페닐)-N-(2,6-디플루오로페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.013) 4-(2-브로모-4-플루오로페닐)-N-(2-브로모-6-플루오로페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.014) 4-(2-브로모-4-플루오로페닐)-N-(2-브로모페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.015) 4-(2-브로모-4-플루오로페닐)-N-(2-클로로-6-플루오로페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.016) 4-(2-브로모-4-플루오로페닐)-N-(2-클로로페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.017) 4-(2-브로모-4-플루오로페닐)-N-(2-플루오로페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.018) 4-(2-클로로-4-플루오로페닐)-N-(2,6-디플루오로페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.019) 4-(2-클로로-4-플루오로페닐)-N-(2-클로로-6-플루오로페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.020) 4-(2-클로로-4-플루오로페닐)-N-(2-클로로페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.021) 4-(2-클로로-4-플루오로페닐)-N-(2-플루오로페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.022) 4-(4-클로로페닐)-5-(2,6-디플루오로페닐)-3,6-디메틸피리다진, (4.023) N-(2-브로모-6-플루오로페닐)-4-(2-클로로-4-플루오로페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.024) N-(2-브로모페닐)-4-(2-클로로-4-플루오로페닐)-1,3-디메틸-1H-피라졸-5-아민, (4.025) N-(4-클로로-2,6-디플루오로페닐)-4-(2-클로로-4-플루오로페닐)-1,3-디메틸-1H-피라졸-5-아민. (4) inhibitors of mitosis and cell division, such as (4.001) carbendazim, (4.002) dietofencarb, (4.003) ethaboxam, (4.004) fluopicolide, (4.005) fencicuron, (4.006) Thiabendazole, (4.007) thiophanate-methyl, (4.008) zoxamide, (4.009) 3-chloro-4- (2,6-difluorophenyl) -6-methyl-5-phenylpyridazine, ( 4.010) 3-chloro-5- (4-chlorophenyl) -4- (2,6-difluorophenyl) -6-methylpyridazine, (4.011) 3-chloro-5- (6-chloropyridine-3 -yl)-6-methyl-4- (2,4,6-trifluorophenyl) pyridazine, (4.012) 4- (2-bromo-4-fluorophenyl) -N- (2,6- Difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.013) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluoro Rophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.014) 4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3 -Dimethyl-1H-pyrazol-5-amine, (4.015) 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl- 1H-Pyrazol-5-amine, (4.016) 4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine , (4.017) 4- (2-bromo-4-fluorophenyl) -N- (2-fluorophenyl) -1,3-dimethyl-1H-pyrazol-5-amine, (4.018) 4- ( 2-Chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.019) 4-(2-chloro-4 -Fluorophenyl) -N- (2-chloro-6-fluorophenyl) -1,3-dimethyl-1H-pyrazol-5-amine, (4.020) 4- (2-chloro-4-fluorophenyl) ) -N- (2-chlorophenyl) -1,3-dimethyl-1H-pyrazol-5-amine, (4.021) 4- (2-chloro-4-fluorophenyl) -N- (2-fluoro Phenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.022) 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine , (4.023) N-( 2-Bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.024) N-(2-bro mophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.025) N-(4-chloro-2,6-difluoro Phenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine.

(5) 다부위에 활성을 보일 수 있는 화합물, 예컨대 (5.001) 보르도액, (5.002) 캡타폴, (5.003) 캡탄, (5.004) 클로르탈로닐(chlorthalonil), (5.005) 수산화구리, (5.006) 나프텐산구리, (5.007) 산화구리, (5.008) 염기성 염화구리, (5.009) 황산구리(2+), (5.010) 디티아논, (5.011) 도다인, (5.012) 폴페트, (5.013) 만제브, (5.014) 만네브, (5.015) 메티람, (5.016) 메티람아연(zinc metiram), (5.017) 옥신구리(copper oxine), (5.018) 프로피네브, (5.019) 황 및 황제(sulfur agent), 예컨대 다황화칼슘, (5.020) 티우람, (5.021) 지네브, (5.022) 지람. (5) compounds capable of exhibiting multisite activity, such as (5.001) Bordeaux solution, (5.002) Captapol, (5.003) Captan, (5.004) Chlorthalonil, (5.005) Copper hydroxide, (5.006) Naph Copper Thenate, (5.007) Copper Oxide, (5.008) Basic Copper Chloride, (5.009) Copper Sulfate (2+), (5.010) Dithianone, (5.011) Dodyne, (5.012) Folpet, (5.013) Manzeb, ( 5.014) manneb, (5.015) methiram, (5.016) zinc metiram, (5.017) copper oxine, (5.018) propineb, (5.019) sulfur and sulfur agent, such as calcium polysulfide, (5.020) thiuram, (5.021) zineb, (5.022) ziram.

(6) 숙주의 방어를 유발할 수 있는 화합물, 예컨대 (6.001) 아시벤조랄-S-메틸, (6.002) 이소티아닐, (6.003) 프로베나졸, (6.004) 티아디닐. (6) Compounds capable of inducing host defense, such as (6.001) acibenzoral-S-methyl, (6.002) isotianil, (6.003) probenazole, (6.004) thiadinyl.

(7) 아미노산 및/또는 단백질의 생합성 저해약, 예컨대 (7.001) 시프로디닐, (7.002) 카수가마이신, (7.003) 카수가마이신 염산염 수화물, (7.004) 옥시테트라사이클린, (7.005) 피리메타닐, (7.006) 3-(5-플루오로-3,3,4,4-테트라메틸-3,4-디히드로이소퀴놀린-1-일)퀴놀린. (7) inhibitors of amino acid and/or protein biosynthesis, such as (7.001) cyprodinil, (7.002) kasugamycin, (7.003) kasugamycin hydrochloride hydrate, (7.004) oxytetracycline, (7.005) pyrimethanil , (7.006) 3-(5-Fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline.

(8) ATP 산생 저해약, 예컨대 (8.001) 실티오팜. (8) ATP production inhibitors, such as (8.001) silthiofam.

(9) 세포벽 합성 저해약, 예컨대 (9.001) 벤티아발리카브, (9.002) 디메토모르프, (9.003) 플루모르프, (9.004) 이프로발리카브, (9.005) 만디프로파미드, (9.006) 피리모르프(pyrimorph), (9.007) 발리페날레이트, (9.008) (2E)-3-(4-tert-부틸페닐)-3-(2-클로로피리딘-4-일)-1-(모르폴린-4-일)프로프-2-엔-1-온, (9.009) (2Z)-3-(4-tert-부틸페닐)-3-(2-클로로피리딘-4-일)-1-(모르폴린-4-일)프로프-2-엔-1-온. (9) cell wall synthesis inhibitors such as (9.001) benthiavalicarb, (9.002) dimethomorph, (9.003) flumorph, (9.004) iprovalicarb, (9.005) mandipropamide, ( 9.006) pyrimorph, (9.007) valifenalate, (9.008) (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-( Morpholin-4-yl)prop-2-en-1-one, (9.009) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1 -(morpholin-4-yl)prop-2-en-1-one.

(10) 지질 및 막의 합성 저해약, 예컨대 (10.001) 프로파모카브, (10.002) 프로파모카브 염산염, (10.003) 톨클로포스-메틸. (10) Inhibitors of synthesis of lipids and membranes, such as (10.001) propamocarb, (10.002) propamocarb hydrochloride, (10.003) tolclofos-methyl.

(11) 멜라닌 생합성 저해약, 예컨대 (11.001) 트리시클라졸, (11.002) 2,2,2-트리플루오로에틸 {3-메틸-1-[(4-메틸벤조일)아미노]부탄-2-일}카바메이트. (11) Melanin biosynthesis inhibitors such as (11.001) tricyclazole, (11.002) 2,2,2-trifluoroethyl {3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl } Carbamate.

(12) 핵산 합성 저해약, 예컨대 (12.001) 베날락실, (12.002) 베날락실-M(키랄락실), (12.003) 메탈락실, (12.004) 메탈락실-M(메페녹삼). (12) nucleic acid synthesis inhibitors, such as (12.001) benalaxyl, (12.002) benalaxyl-M (chiralaxyl), (12.003) metalaxyl, (12.004) metalaxyl-M (mefenoxam).

(13) 시그널 전달 저해약, 예컨대 (13.001) 플루디옥소닐, (13.002) 이프로디온, (13.003) 프로시미돈, (13.004) 프로퀴나지드, (13.005) 퀴녹시펜, (13.006) 빈클로졸린. (13) signal transduction inhibitors such as (13.001) fludioxonil, (13.002) iprodione, (13.003) procymidone, (13.004) proquinazide, (13.005) quinoxifene, (13.006) vinclozoline .

(14) 탈공역제로서 작용할 수 있는 화합물, 예컨대 (14.001) 플루아지남, (14.002) 멥틸디노캅. (14) Compounds capable of acting as deconjugation agents, such as (14.001) fluazinam, (14.002) meptyldinocap.

(15) 추가적인 화합물, 예컨대 (15.001) 아브시스산, (15.002) 벤티아졸, (15.003) 벤톡사진, (15.004) 캅시마이신(capsimycin), (15.005) 카르본, (15.006) 키노메티오네이트, (15.007) 쿠프라네브, (15.008) 시플루페나미드, (15.009) 시목사닐, (15.010) 시프로설파미드, (15.011) 플루티아닐, (15.012) 포세틸-알루미늄, (15.013) 포세틸-칼슘, (15.014) 포세틸-나트륨, (15.015) 이소티오시안산메틸, (15.016) 메트라페논, (15.017) 밀디오마이신, (15.018) 나타마이신, (15.019) 디메틸디티오카르밤산니켈, (15.020) 니트로탈-이소프로필, (15.021) 옥사모카브(oxamocarb), (15.022) 옥사티아피프롤린, (15.023) 옥시펜티인(oxyfenthiin), (15.024) 펜타클로로페놀 및 염, (15.025) 포스폰산 및 그의 염, (15.026) 프로파모카브-포세틸레이트(propamocarb-fosetylate), (15.027) 피리오페논(클라자페논(chlazafenone)), (15.028) 테부플로퀸, (15.029) 테클로프탈람, (15.030) 톨니파니드, (15.031) 1-(4-{4-[(5R)-5-(2,6-디플루오로페닐)-4,5-디히드로-1,2-옥사졸-3-일]-1,3-티아졸-2-일}피페리딘-1-일)-2-[5-메틸-3-(트리플루오로메틸)-1H-피라졸-1-일]에탄온, (15.032) 1-(4-{4-[(5S)-5-(2,6-디플루오로페닐)-4,5-디히드로-1,2-옥사졸-3-일]-1,3-티아졸-2-일}피페리딘-1-일)-2-[5-메틸-3-(트리플루오로메틸)-1H-피라졸-1-일]에탄온, (15.033) 2-(6-벤질피리딘-2-일)퀴나졸린, (15.034) 2,6-디메틸-1H,5H-[1,4]디티이노[2,3-c:5,6-c']디피롤-1,3,5,7(2H,6H)-테트론, (15.035) 2-[3,5-비스(디플루오로메틸)-1H-피라졸-1-일]-1-[4-(4-{5-[2-(프로프-2-인-1-일옥시)페닐]-4,5-디히드로-1,2-옥사졸-3-일}-1,3-티아졸-2-일)피페리딘-1-일]에탄온, (15.036) 2-[3,5-비스(디플루오로메틸)-1H-피라졸-1-일]-1-[4-(4-{5-[2-클로로-6-(프로프-2-인-1-일옥시)페닐]-4,5-디히드로-1,2-옥사졸-3-일}-1,3-티아졸-2-일)피페리딘-1-일]에탄온, (15.037) 2-[3,5-비스(디플루오로메틸)-1H-피라졸-1-일]-1-[4-(4-{5-[2-플루오로-6-(프로프-2-인-1-일옥시)페닐]-4,5-디히드로-1,2-옥사졸-3-일}-1,3-티아졸-2-일)피페리딘-1-일]에탄온, (15.038) 2-[6-(3-플루오로-4-메톡시페닐)-5-메틸피리딘-2-일]퀴나졸린, (15.039) 2-{(5R)-3-[2-(1-{[3,5-비스(디플루오로메틸)-1H-피라졸-1-일]아세틸}피페리딘-4-일)-1,3-티아졸-4-일]-4,5-디히드로-1,2-옥사졸-5-일}-3-클로로페닐 메탄술포네이트, (15.040) 2-{(5S)-3-[2-(1-{[3,5-비스(디플루오로메틸)-1H-피라졸-1-일]아세틸}피페리딘-4-일)-1,3-티아졸-4-일]-4,5-디히드로-1,2-옥사졸-5-일}-3-클로로페닐 메탄술포네이트, (15.041) 2-{2-[(7,8-디플루오로-2-메틸퀴놀린-3-일)옥시]-6-플루오로페닐}프로판-2-올, (15.042) 2-{2-플루오로-6-[(8-플루오로-2-메틸퀴놀린-3-일)옥시]페닐}프로판-2-올, (15.043) 2-{3-[2-(1-{[3,5-비스(디플루오로메틸)-1H-피라졸-1-일]아세틸}피페리딘-4-일)-1,3-티아졸-4-일]-4,5-디히드로-1,2-옥사졸-5-일}-3-클로로페닐 메탄술포네이트, (15.044) 2-{3-[2-(1-{[3,5-비스(디플루오로메틸)-1H-피라졸-1-일]아세틸}피페리딘-4-일)-1,3-티아졸-4-일]-4,5-디히드로-1,2-옥사졸-5-일}페닐메탄술포네이트, (15.045) 2-페닐페놀 및 그의 염, (15.046) 3-(4,4,5-트리플루오로-3,3-디메틸-3,4-디히드로이소퀴놀린-1-일)퀴놀린, (15.047) 3-(4,4-디플루오로-3,3-디메틸-3,4-디히드로이소퀴놀린-1-일)퀴놀린, (15.048) 4-아미노-5-플루오로피리미딘-2-올(호변 이성체 형태: 4-아미노-5-플루오로피리미딘-2(1H)-온), (15.049) 4-옥소-4-[(2-페닐에틸)아미노]부티르산, (15.050) 5-아미노-1,3,4-티아디아졸-2-티올, (15.051) 5-클로로-N'-페닐-N'-(프로프-2-인-1-일)티오펜 2-술포노히드라지드, (15.052) 5-플루오로-2-[(4-플루오로벤질)옥시]피리미딘-4-아민, (15.053) 5-플루오로-2-[(4-메틸벤질)옥시]피리미딘-4-아민, (15.054) 9-플루오로-2,2-디메틸-5-(퀴놀린-3-일)-2,3-디히드로-1,4-벤조옥사제핀, (15.055) 부트-3-인-1-일{6-[({[(Z)-(1-메틸-1H-테트라졸-5-일)(페닐)메틸렌]아미노}옥시)메틸]피리딘-2-일}카바메이트, (15.056) (2Z)-3-아미노-2-시아노-3-페닐아크릴산에틸, (15.057) 페나진-1-카르복실산, (15.058) 3,4,5-트리히드록시안식향산프로필, (15.059) 퀴놀린-8-올, (15.060) 퀴놀린-8-올 설페이트(2:1), (15.061) {6-[({[(1-메틸-1H-테트라졸-5-일)(페닐)메틸렌]아미노}옥시)메틸]피리딘-2-일}카르밤산tert-부틸. (15) additional compounds, such as (15.001) abscisic acid, (15.002) benthiazole, (15.003) bentoxazine, (15.004) capsimycin, (15.005) carbonone, (15.006) quinomethionate, (15.007) cupraneb, (15.008) cyflufenamide, (15.009) simoxanil, (15.010) ciprosulfamide, (15.011) flutianil, (15.012) fosetyl-aluminum, (15.013) fosetyl- Calcium, (15.014) fosetyl-sodium, (15.015) methyl isothiocyanate, (15.016) metraphenone, (15.017) mildiomycin, (15.018) natamycin, (15.019) dimethyldithiocarbamate nickel, ( 15.020) nitrotal-isopropyl, (15.021) oxamocarb, (15.022) oxathiapiproline, (15.023) oxyfenthiin, (15.024) pentachlorophenol and salts, (15.025) phosphonic acid and salts thereof, (15.026) propamocarb-fosetylate, (15.027) pyriophenone (chlazafenone), (15.028) tebufloquine, (15.029) teclophthalam, (15.030) tolniphanide, (15.031) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazole- 3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl] Ethanone, (15.032) 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, ( 15.033) 2-(6-benzylpyridin-2-yl)quinazoline, (15.034) 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c' ]dipyrrole-1,3,5,7(2H,6H)-tetron, (15.035) 2-[3,5-bis(difluoromethyl)-1H- Pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxa zol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.036) 2-[3,5-bis(difluoromethyl)-1H-pyra zol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1, 2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.037) 2-[3,5-bis(difluoromethyl)- 1H-Pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-di Hydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.038) 2-[6-(3-fluoro- 4-Methoxyphenyl)-5-methylpyridin-2-yl]quinazoline, (15.039) 2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl) -1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl }-3-Chlorophenyl methanesulfonate, (15.040) 2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl) ]Acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate , (15.041) 2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2-ol, (15.042) 2-{2 -fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol, (15.043) 2-{3-[2-(1-{[3, 5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1 ,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (15.044) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyra) zol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenylmethanesulfo nate, (15.045) 2-phenylphenol and its salts, (1 5.046) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.047) 3-(4,4-difluoro- 3,3-Dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.048) 4-amino-5-fluoropyrimidin-2-ol (tautomeric form: 4-amino-5-fluoro Lopyrimidin-2(1H)-one), (15.049) 4-oxo-4-[(2-phenylethyl)amino]butyric acid, (15.050) 5-amino-1,3,4-thiadiazole-2 -thiol, (15.051) 5-chloro-N'-phenyl-N'- (prop-2-yn-1-yl) thiophene 2-sulfonohydrazide, (15.052) 5-fluoro-2-[ (4-fluorobenzyl)oxy]pyrimidin-4-amine, (15.053) 5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine, (15.054) 9-fluoro- 2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxazepine, (15.055) but-3-yn-1-yl {6-[({[ (Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, (15.056) (2Z)-3-amino-2 -Cyano-3-phenyl ethyl acrylate, (15.057) phenazine-1-carboxylic acid, (15.058) 3,4,5-trihydroxypropyl benzoate, (15.059) quinolin-8-ol, (15.060) quinoline -8-ol sulfate (2:1), (15.061) {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2- One} tert-butyl carbamic acid.

미생물제, 유익 생물로서, 특히 세균류, 균류, 효모류, 식물 추출물 및 미생물에 의해 형성되는 생성물(예컨대, 단백질 및 이차 대사 산물) 등이 있다. Microbial agents, beneficial organisms, in particular bacteria, fungi, yeasts, plant extracts and products formed by microorganisms (eg, proteins and secondary metabolites), and the like.

세균류, 예컨대 아포(芽胞) 형성성 세균, 뿌리에 콜로니를 형성하는 세균 및 생물학적 살충제, 살균제 또는 살선충제로서 작용하는 세균 등이 있다. bacteria such as spore-forming bacteria, bacteria that colonize roots and bacteria that act as biological insecticides, fungicides or nematicides, and the like.

상기 세균류의 예는 이하의 것이다: Examples of such bacteria are:

바실루스 아밀롤리퀘파시엔스(Bacillus amyloliquefaciens) 주 FZB42(DSM 231179) 또는 바실루스 세레우스(Bacillus cereus), 특히 바실루스 세레우스(B. cereus) 주 CNCM I-1562 또는 바실루스 피르무스(Bacillus firmus) 주 I-1582(수탁 번호 CNCM I-1582) 또는 바실루스 푸밀루스(Bacillus pumilus), 특히 주 GB34(수탁 번호 ATCC 700814) 및 주 QST2808(수탁 번호 NRRL B-30087) 또는 바실루스 서브틸리스(Bacillus subtilis), 특히 주 GB03(수탁 번호 ATCC SD-1397) 또는 바실루스 서브틸리스(Bacillus subtilis) 주 QST713(수탁 번호 NRRL B-21661) 또는 바실루스 서브틸리스(Bacillus subtilis) 주 OST 30002(수탁 번호 NRRL B-50421), 바실루스 투린기엔시스(Bacillus thuringiensis), 특히 바실루스 투린기엔시스 아종 이스라엘렌시스(B. thuringiensis subspecies israelensis)(항원형 H-14) 주 AM65-52(수탁 번호 ATCC 1276) 또는 바실루스 투린기엔시스 아종 아이자와이(B. thuringiensis subsp. aizawai), 특히 주 ABTS-1857(SD-1372) 또는 바실루스 투린기엔시스 아종 쿠르스타키(B. thuringiensis subsp. kurstaki) 주 HD-1 또는 바실루스 투린기엔시스 아종 테네브리오니스(B. thuringiensis subsp. tenebrionis) 주 NB 176(SD-5428), 파스테우리아 페네트란스(Pasteuria penetrans), 파스테우리아속종(Pasteuria spp.)(로틸렌쿨루스 레니포르미스(Rotylenchulus reniformis) 선충)-PR3(수탁 번호 ATCC SD-5834), 스트렙토미세스 미크로플라부스(Streptomyces microflavus) 주 AQ6121(=QRD 31.013, NRRL B-50550), 스트렙토미세스 갈부스(Streptomyces galbus) 주 AQ 6047(수탁 번호 NRRL30232). Bacillus amyloliquefaciens strain FZB42 (DSM 231179) or Bacillus cereus, especially B. cereus strain CNCM I-1562 or Bacillus firmus strain I- 1582 (Accession No. CNCM I-1582) or Bacillus pumilus, especially strain GB34 (Accession No. ATCC 700814) and strain QST2808 (Accession No. NRRL B-30087) or Bacillus subtilis, especially strain GB03 (Accession No. ATCC SD-1397) or Bacillus subtilis strain QST713 (Accession No. NRRL B-21661) or Bacillus subtilis strain OST 30002 (Accession No. NRRL B-50421), Bacillus Bacillus thuringiensis, in particular B. thuringiensis subspecies israelensis (antigen type H-14) strain AM65-52 (accession number ATCC 1276) or Bacillus thuringiensis subspecies israelensis (B) thuringiensis subsp. aizawai), in particular strain ABTS-1857 (SD-1372) or B. thuringiensis subsp. kurstaki strain HD-1 or B. thuringiensis subspecies tenebrionis (B. thuringiensis) subsp. tenebrionis) strain NB 176 (SD-5428), Pasteuria penetrans, Pasteuria spp. (Rotylenchulus reniformis nematode)-PR3 (Accession No. ATCC SD-5834), Streptomyces microflavus (Streptomyc) es microflavus) strain AQ6121 (=QRD 31.013, NRRL B-50550), Streptomyces galbus strain AQ 6047 (accession number NRRL30232).

균류 및 효모류의 예는 이하의 것이다: Examples of fungi and yeasts are:

베아우베리아 바시아나(Beauveria bassiana), 특히 주 ATCC 74040, 코니오티륨 미니탄스(Coniothyrium minitans), 특히 주 CON/M/91-8(수탁 번호 DSM-9660), 레카니실리움속종(Lecanicillium spp.), 특히 주 HRO LEC 12, 레카니실리움 레카니이(Lecanicillium lecanii)(이전에는 베리티실리움 레카니이(Verticillium lecanii)로서 알려져 있었다), 특히 주 KV01, 메타리지움 아니소플리아에(Metarhizium anisopliae), 특히 주 F52(DSM3884/ATCC 90448), 메츄니코위아 프룩티콜라(Metschnikowia fructicola), 특히 주 NRRL Y-30752, 파에실로미세스 푸모소로세우스(Paecilomyces fumosoroseus)(신규: 이사리아 푸모소로세아(Isaria fumosorosea)), 특히 주 IFPC 200613 또는 주 Apopka 97(수탁 번호 ATCC 20874), 파에실로미세스 릴라시누스(Paecilomyces lilacinus), 특히 파에실로미세스 릴라시누스(P. lilacinus) 주 251(AGAL 89/030550), 탈라로미세스 플라부스(Talaromyces flavus), 특히 주 V117b, 트리코데르마 아트로비리데(Trichoderma atroviride), 특히 주 SC1(수탁 번호 CBS 122089), 트리코데르마 하지아눔(Trichoderma harzianum), 특히 트리코데르마 하지아눔 리파이(T. harzianum rifai) T39(수탁 번호 CNCM I-952). Beauveria bassiana, in particular state ATCC 74040, Coniothyrium minitans, in particular state CON/M/91-8 (Accession No. DSM-9660), Lecanicillium spp. ), especially the strain HRO LEC 12, Lecanicillium lecanii (previously known as Verticillium lecanii), especially the strain KV01, Metarhizium anisopliae , especially strain F52 (DSM3884/ATCC 90448), Metschnikowia fructicola, especially strain NRRL Y-30752, Paecilomyces fumosoroseus (new: Isaria fumosoroseus) (Isaria fumosorosea)), in particular the state IFPC 200613 or the state Apopka 97 (accession number ATCC 20874), Paecilomyces lilacinus, in particular P. lilacinus, note 251 (AGAL 89/ 030550), Talaromyces flavus, especially strain V117b, Trichoderma atroviride, especially strain SC1 (Accession No. CBS 122089), Trichoderma harzianum, especially T. harzianum rifai T39 (Accession No. CNCM I-952).

바이러스류의 예는 이하의 것이다: Examples of viruses are:

애모무늬잎말이나방(Adoxophyes orana) 과립병 바이러스(GV), 코드링나방(Cydia pomonella) 과립병 바이러스(GV), 왕담배나방(Helicoverpa armigera) 핵다각체병 바이러스(NPV), 파밤나방(Spodoptera exigua) mNPV, 열대거세미나방(Spodoptera frugiperda) mNPV, 아프리카 면화 엽충(African cotton leafworm)(Spodoptera littoralis) NPV. Adoxophyes orana granule disease virus (GV), cydia pomonella granule disease virus (GV), tobacco moth (Helicoverpa armigera) nuclear polyhedron virus (NPV), Spodoptera exigua mNPV, Spodoptera frugiperda mNPV, African cotton leafworm (Spodoptera littoralis) NPV.

식물 또는 식물의 부분 또는 식물의 기관에 대하여 「접종원」으로서 더해지며, 이들 특정 특성에 의해서 식물의 성장 및 식물의 건강을 증진하는 세균류 및 균류도 마찬가지로 포함된다. 예로서는 이하의 것을 들 수 있다: Bacteria and fungi which are added as "inoculum" to a plant or plant part or plant organ, and which promote plant growth and plant health by virtue of these specific properties are likewise included. Examples include:

아그로박테리움속종(Agrobacterium spp.), 아조리조븀 카울리노단스(Azorhizobium caulinodans), 아조스피릴륨속종(Azospirillum spp.), 아조토박터속종(Azotobacter spp.), 브라디리조븀속종(Bradyrhizobium spp.), 부르크홀데리아속종(Burkholderia spp.), 특히 부르크홀데리아 세파시아(Burkholderia cepacia)(이전에는 슈도모나스 세파시아(Pseudomonas cepacia)로서 알려져 있었다), 기가스포라속종(Gigaspora spp.) 또는 기가스포라 모노스포룸(Gigaspora monosporum), 글로무스속종(Glomus spp.), 라카리아속종(Laccaria spp.), 락토바실루스 부크네리(Lactobacillus buchneri), 파라글로무스속종(Paraglomus spp.), 피솔리투스 틴크토루스(Pisolithus tinctorus), 슈도모나스속종(Pseudomonas spp.), 리조비움속종(Rhizobium spp.), 특히 리조비움 트리폴리이(Rhizobium trifolii), 리조포곤속종(Rhizopogon spp.), 스클레로데르마속종(Scleroderma spp.), 수일루스속종(Suillus spp.), 스트렙토미세스속종(Streptomyces spp.). Agrobacterium spp., Azorhizobium caulinodans, Azospirillum spp., Azotobacter spp., Bradyrhizobium pp. ), Burkholderia spp., in particular Burkholderia cepacia (previously known as Pseudomonas cepacia), Gigaspora spp. or Gigaspora monospo Gigaspora monosporum, Glomus spp., Laccaria spp., Lactobacillus buchneri, Paraglomus spp., Pysolitus tincture (Pisolithus tinctorus), Pseudomonas spp., Rhizobium spp., especially Rhizobium trifolii, Rhizobium trifolii, Rhizopogon spp., Scleroderma spp. ), Suillus spp., Streptomyces spp.).

식물 추출물 및 미생물에 의해서 형성되는 생성물(이것은 단백질 및 이차 대사 산물을 포함한다)의 예는 이하의 것이다: Examples of plant extracts and products formed by microorganisms (which include proteins and secondary metabolites) are:

마늘(Allium sativum), 고애(Artemisia absinthium), 아자디라크틴(azadirachtin), Biokeeper WP, 카시아 니그리칸스(Cassia nigricans), 셀라스트루스 앙굴라투스(Celastrus angulatus), 아메리카 향능쟁이(Chenopodium anthelminticum), 키틴, Armour-Zen, 서양 면마(Dryopteris filix-mas), 쇠뜨기(Equisetum arvense), Fortune Aza, Fungastop, Heads Up(퀴노아(Chenopodium quinoa) 사포닌 추출물), 제충국(pyrethrum/pyrethrins), 수리남 떡갈나무(Quassia amara), 참나무속(Quercus), 퀼라야속(Quillaja), Regalia, (「RequiemTM Insecticide」), 로테논, 리아니아/리아노딘, 컴프리(Symphytum officinale), 쑥국화(Tanacetum vulgare), 티몰, Triact 70, TriCon, 금연화(Tropaeulum majus), 서양 쐐기풀(Urtica dioica), Veratrin, 서양 겨우살이(Viscum album), 십자화과(Brassicaceae) 추출물, 특히 유채씨 분말 또는 겨자 분말. Garlic (Allium sativum), bitter gourd (Artemisia absinthium), azadirachtin, Biokeeper WP, Cassia nigricans, Celastrus angulatus, American sagebrush (Chenopodium anthelminticum), Chitin, Armor-Zen, Dryopteris filix-mas, Horsetail (Equisetum arvense), Fortune Aza, Fungastop, Heads Up (Chenopodium quinoa saponin extract), pyrethrum/pyrethrins, Surinamese oak ( Quassia amara), Quercus, Quillaja, Regalia, (「Requiem TM Insecticide」), rotenone, liana/ryanodine, comfrey (Symphytum officinale), mugwort (Tanacetum vulgare), thymol , Triact 70, TriCon, Tropaeulum majus, Urtica dioica, Veratrin, Viscum album, Brassicaceae extract, especially rapeseed powder or mustard powder.

본 발명에 따른 스멕타이트 광물에는, 바람직하게는 몬모릴로나이트, 바이델라이트, 논트로나이트, 사포나이트, 헥토라이트, 소코나이트 및 스티벤사이트를 들 수 있다. 몬모릴로나이트를 주성분으로서 포함하는 벤토나이트도 본 발명에 따른 스멕타이트 광물에 포함된다. 본 발명에 따른 스멕타이트 광물에는 벤토나이트가 적합하다. The smectite mineral according to the present invention preferably includes montmorillonite, weidellite, nontronite, saponite, hectorite, soconite and stevensite. Bentonite containing montmorillonite as a main component is also included in the smectite mineral according to the present invention. Bentonite is suitable for the smectite mineral according to the present invention.

본 발명에 따른 알킬나프탈렌술폰산 유도체에는, 바람직하게는 나프탈렌술폰산 포르말린 축합물 나트륨염, 알킬나프탈렌술폰산 포르말린 축합물 나트륨염을 들 수 있고, 알킬나프탈렌술폰산 포르말린 축합물 나트륨염이 적합하다. The alkylnaphthalenesulfonic acid derivative according to the present invention preferably includes sodium salt of naphthalenesulfonic acid formalin condensate and sodium salt of alkylnaphthalenesulfonic acid formalin condensate, and alkylnaphthalenesulfonic acid formalin condensate sodium salt is suitable.

본 발명의 농약 입제 조성물에 있어서의, 알킬나프탈렌술폰산 유도체의 함유 비율은, 적합하게는 0.1∼2.0 중량%이며, 더욱 적합하게는 0.15∼0.75 중량%이고, 더욱 적합하게는 0.2∼0.6 중량%이다. The content rate of the alkylnaphthalenesulfonic acid derivative in the agrochemical granular composition of this invention is 0.1 to 2.0 weight% suitably, More preferably, it is 0.15 to 0.75 weight%, More preferably, it is 0.2 to 0.6 weight% .

본 발명의 농약 입제 조성물에 있어서의, 알파화 전분의 함유 비율은, 적합하게는 0.1∼10 중량%이며, 더욱 적합하게는 0.2∼5 중량%이고, 더욱 적합하게는 0.5∼3 중량%이다. The content rate of the pregelatinized starch in the agrochemical granular composition of this invention is 0.1 to 10 weight% suitably, More preferably, it is 0.2 to 5 weight%, More preferably, it is 0.5 to 3 weight%.

본 발명의 농약 입제 조성물에 있어서의, 스멕타이트 광물의 함유 비율은, 적합하게는 1∼50 중량%이며, 더욱 적합하게는 2∼30 중량%이고, 더욱 적합하게는 3∼20 중량%이다. The content rate of the smectite mineral in the agrochemical granular composition of this invention is 1 to 50 weight% suitably, More preferably, it is 2 to 30 weight%, More preferably, it is 3 to 20 weight%.

본 발명의 농약 입제 조성물은, 또한 증량제, 수용성 결합제, 계면활성제, 용제, 안정제, 조립촉진제, 방부제, 착색료, pH 조정제, 향료 등의 조제를 포함할 수 있다. The agrochemical granular composition of the present invention may further contain adjuvants such as extenders, water-soluble binders, surfactants, solvents, stabilizers, granulation accelerators, preservatives, colorants, pH adjusters, fragrances and the like.

증량제에는, 클레이, 탄산칼슘, 실리카 샌드 및 그의 분쇄물, 규조토, 탈크, 지클라이트, 세리사이트, 산성 백토, 활성 백토, 규석, 경석, 제올라이트, 버미큘라이트, 화이트 카본, 시라스 벌룬 등을 분쇄한 유리질 분말 등의 무기 담체, 또는 셀룰로오스, 펄프, 왕겨, 목분, 전분, 대두분 등 비수용성 유기물 담체, 요소, 유당, 자당, 식염, 망초, 시트르산 무수물 등의 수용성 고체 담체를 들 수 있다.Examples of the extender include clay, calcium carbonate, silica sand and pulverized products thereof, diatomaceous earth, talc, ziclerite, sericite, acid clay, activated clay, silica stone, pumice stone, zeolite, vermiculite, white carbon, shirasu balloon, and the like. inorganic carriers such as cellulose, pulp, rice husk, wood flour, starch, soybean flour and other water-insoluble organic matter carriers;

수용성 결합제에는, 카르복시메틸셀룰로오스나트륨, 히드록시프로필메틸셀룰로오스, 메틸셀룰로오스, 메틸에틸셀룰로오스, 히드록시프로필셀룰로오스, 폴리아크릴산나트륨, 트래거칸트 검, 폴리비닐피롤리돈, 폴리비닐알코올, 덱스트린, 알긴산 및 알긴산나트륨 등을 들 수 있다. Water-soluble binders include sodium carboxymethylcellulose, hydroxypropylmethylcellulose, methylcellulose, methylethylcellulose, hydroxypropylcellulose, sodium polyacrylate, gum tragacanth, polyvinylpyrrolidone, polyvinyl alcohol, dextrin, alginic acid and Sodium alginate etc. are mentioned.

계면활성제에는, 비이온 계면활성제, 음이온 계면활성제, 양이온 계면활성제 및 양면활성제 등을 들 수 있다.Nonionic surfactants, anionic surfactants, cationic surfactants, double-sided active agents, etc. are mentioned to surfactant.

예컨대, 비이온 계면활성제로서는, 폴리옥시알킬렌알킬에테르, 폴리옥시알킬렌알킬아릴에테르, 폴리옥시알킬렌알릴페닐에테르, 폴리옥시알킬렌알킬에스테르, 폴리옥시알킬렌소르비탄알킬레이트, 폴리옥시알킬렌페닐에테르 폴리머, 폴리옥시알킬렌알킬렌아릴페닐에테르, 폴리옥시알킬렌알킬렌글리콜, 폴리옥시에틸렌폴리옥시프로필렌 블록 폴리머 등을 들 수 있다. For example, as a nonionic surfactant, polyoxyalkylene alkyl ether, polyoxyalkylene alkyl aryl ether, polyoxyalkylene allyl phenyl ether, polyoxyalkylene alkyl ester, polyoxyalkylene sorbitan alkylate, polyoxyalkyl A enephenyl ether polymer, polyoxyalkylene alkylene aryl phenyl ether, polyoxyalkylene alkylene glycol, a polyoxyethylene polyoxypropylene block polymer, etc. are mentioned.

음이온 계면활성제로서는, 리그닌술폰산염, 알킬아릴술폰산염, 디알킬술포숙시네이트, 폴리옥시알킬렌알킬아릴에테르설페이트염, 알킬나프탈렌술폰산염, 폴리옥시알킬렌알릴페닐에테르설페이트염, 라우릴황산염 등을 들 수 있다. Examples of the anionic surfactant include lignin sulfonate, alkylarylsulfonate, dialkylsulfosuccinate, polyoxyalkylenealkylarylethersulfate, alkylnaphthalenesulfonate, polyoxyalkyleneallylphenylethersulfate, laurylsulfate, and the like. can be heard

양이온 계면활성제로서는, 알킬트리메틸암모늄염, 알킬디메틸벤질암모늄염, 알킬피리디늄염 등을 들 수 있다. Examples of the cationic surfactant include alkyltrimethylammonium salts, alkyldimethylbenzylammonium salts, and alkylpyridinium salts.

양면활성제로서는, 디알킬디아미노에틸베타인, 알킬디메틸벤질베타인 등을 들 수 있다. 단, 본 발명에 있어서 사용할 수 있는 계면활성제는 이들 예시에 한정되는 것은 아니며, 1종 또는 2종 이상을 병용하여도 하등 문제는 없다. Examples of the double-sided active agent include dialkyldiaminoethylbetaine and alkyldimethylbenzylbetaine. However, the surfactant which can be used in this invention is not limited to these illustrations, Even if it uses 1 type or 2 or more types together, there is no problem at all.

pH 조정제에는, 시트르산, 사과산, 인산, 시트르산나트륨, 시트르산칼륨, 산화마그네슘, 탄산나트륨, 탄산수소나트륨, 인산수소이나트륨, 인산수소이칼륨, 인산삼나트륨, 피롤린산칼륨 또는 피롤린산나트륨, 또는 이들의 함수물, 무수 결정 등을 들 수 있다. 단, 본 발명에 있어서 사용할 수 있는 pH 조정제는 이들 예시에 한정되는 것은 아니며, 1종 또는 2종 이상을 병용하여도 하등 문제는 없다. Examples of the pH adjuster include citric acid, malic acid, phosphoric acid, sodium citrate, potassium citrate, magnesium oxide, sodium carbonate, sodium hydrogen carbonate, disodium hydrogen phosphate, dipotassium hydrogen phosphate, trisodium phosphate, potassium pyrophosphate or sodium pyrrolate, or a hydrous product thereof. , anhydrous crystals, and the like. However, the pH adjuster which can be used in this invention is not limited to these illustrations, Even if it uses 1 type or 2 or more types together, there is no problem at all.

본 발명의 농약 입제 조성물은 그 자체 기지의 제법에 의해 제조할 수 있다. 예컨대, 농약 활성 성분, 스멕타이트 광물, 알파화 전분, 알킬나프탈렌술폰산 유도체, 또 필요에 따라, 증량제, 수용성 결합제, 계면활성제, 용제, 안정제, pH 조정제, 조립촉진제, 방부제, 착색료, 향료 등의 조제와 함께, 피복법이나 반죽법 등의 방법에 의해 조립(造粒)함으로써 원하는 농약 입제를 조제할 수 있다. The agrochemical granular composition of this invention can be manufactured by a manufacturing method known per se. For example, agrochemical active ingredients, smectite minerals, pregelatinized starch, alkylnaphthalenesulfonic acid derivatives, and, if necessary, extenders, water-soluble binders, surfactants, solvents, stabilizers, pH adjusters, granulation accelerators, preservatives, coloring agents, fragrances, etc. Together, the desired agricultural chemical granules can be prepared by granulating by methods, such as a coating method and a kneading method.

피복형 입제의 경우, 농약 활성 성분, 스멕타이트 광물, 알파화 전분, 알킬나프탈렌술폰산 유도체는, 피복층에 포함되어도 좋고, 흡수성의 입핵(粒核)에 함침시키더라도 좋다. In the case of coated granules, the agrochemical active ingredient, smectite mineral, pregelatinized starch, and alkylnaphthalenesulfonic acid derivative may be contained in the coating layer, or the absorbent granules may be impregnated.

피복형 입제를 제조하는 경우, 예컨대 입핵에 물과 계면활성제의 혼합 용액을 가하여 혼합하고, 얻어지는 혼합물로, 농약 활성 성분, 스멕타이트 광물, 알파화 전분, 알킬나프탈렌술폰산 유도체, 기타, 상기한 조제를 가하여 혼합 분쇄하여 조제한 벌크 분말을 피복한 후, 건조, 필요에 따라 해쇄, 체질, 정립(整粒) 등을 행하여 원하는 농약 입제를 제조할 수 있다. In the case of producing coated granules, for example, a mixed solution of water and a surfactant is added to the grains and mixed, and the resulting mixture is obtained by adding agrochemical active ingredient, smectite mineral, pregelatinized starch, alkylnaphthalenesulfonic acid derivative, etc. After coating the bulk powder prepared by mixing and pulverizing, drying, if necessary, pulverization, sieving, sizing, etc. can be performed to produce a desired agrochemical granule.

피복형 입제에 있어서, 입핵으로서는, 예컨대 석회암, 대리석 등의 탄산칼슘 성분, 실리카 샌드, 경석, 클레이 입자, 조립한 무기 물질 입자 등을 들 수 있다. In the coated granule, examples of the nuclei include calcium carbonate components such as limestone and marble, silica sand, pumice stone, clay particles, and granulated inorganic substance particles.

한편, 반죽 입제를 제조하는 경우에는, 농약 활성 성분과, 스멕타이트 광물, 알파화 전분, 알킬나프탈렌술폰산 유도체, 기타 상기한 조제를 함께 혼합하고, 물을 가하여 잘 혼합 또는 혼련하고, 조립하고, 얻어진 조립물(造粒物)을 건조하고, 필요에 따라 해쇄, 체질, 정립 등을 행하여 원하는 농약 입제를 제조할 수 있다. On the other hand, in the case of producing dough granules, the agrochemical active ingredient, smectite mineral, pregelatinized starch, alkylnaphthalenesulfonic acid derivative, and other above-mentioned auxiliary are mixed together, and water is added to mix or knead well, granulation, and granulation obtained Desired pesticide granules can be manufactured by drying water and, if necessary, pulverizing, sieving, sizing, and the like.

상기 혼련에는 혼련기가 이용된다. 혼련기로서는, 만능 혼합기, 니더, 뢰디게 믹서(Loedige mixer), 버티컬 그래뉼레이터(vertical granulator) 등을 들 수 있다. A kneader is used for the kneading. Examples of the kneader include a universal mixer, a kneader, a Loedige mixer, and a vertical granulator.

혼련 시에 이용되는 물의 양은, 상기 혼합물 100 중량부에 대하여 통상 5∼20 중량부의 비율이다. The amount of water used at the time of kneading is usually 5 to 20 parts by weight based on 100 parts by weight of the mixture.

상기 반죽 입제를 제조하는 경우, 통상 0.3∼1.8 mmφ, 바람직하게는 0.8∼1.2 mmφ의 스크린을 이용하여 행해진다.In the case of producing the dough granules, it is usually performed using a screen of 0.3 to 1.8 mm phi, preferably 0.8 to 1.2 mm phi.

이용되는 조립기로서는, 스크류형 압출 조립기, 롤형 압출 조립기, 디스크 펠리터형 압출 조립기, 펠릿밀형 압출 조립기, 바스켓형 압출 조립기, 플레이트형 압출 조립기, 오실레이팅형 압출 조립기, 기어식 압출 조립기, 링다이스식 압출 조립기 등을 들 수 있고, 구체적으로는 멀티그란 MG-55-2; DALTON CORPORATION을 이용할 수 있다. As the granulator used, a screw type extrusion granulator, a roll type extrusion granulator, a disk pellet type extrusion granulator, a pellet mill type extrusion granulator, a basket type extrusion granulator, a plate type extrusion granulator, an oscillating type extrusion granulator, a gear type extrusion granulator, a ring die type Extrusion granulator etc. are mentioned, Specifically, Multigran MG-55-2; DALTON CORPORATION is available.

얻어진 조립물은, 통상 50∼120℃, 바람직하게는 60∼80℃에서 건조된다. The obtained granulated product is usually dried at 50 to 120°C, preferably at 60 to 80°C.

본 발명의 농약 입제 조성물은 파종 전부터 이식 동시까지의 임의의 시기에 시용할 수 있다. The agrochemical granular composition of the present invention can be applied at any time from before sowing to the same time as transplanting.

파종 전의 시용에서는, 예컨대 농약 입제 조성물과 상토를 혼화한 것을 육묘 상자에 넣고, 이어서 종자를 파종하는 방법을 들 수 있다. In the application before sowing, for example, a method of putting a mixture of an agricultural chemical granular composition and top soil into a seedling box and then sowing a seed is exemplified.

파종 시의 시용에서는, 종자 파종 후, 복토 전에 고형 농약 조성물을 살포하는 방법 등을 들 수 있다. In application at the time of sowing, the method of spraying a solid agrochemical composition after seed sowing and before cover is mentioned.

이식 시의 시용에서는, 예컨대 묘를 논이나 밭에 이식하기 수일 전∼당일에 농약 입제 조성물을 육묘 상자에 살포하는 방법, 모내기 기기 등으로 묘를 이식함과 동시에 고형 농약 조성물을 살포기로 살포하는 방법 등을 들 수 있다. In the application at the time of transplantation, for example, a method of spraying a pesticide granular composition in a seedling box a few days before or on the day before transplanting a seedling into a rice paddy or a field, a method of transplanting a seedling with a rice planting device, etc. and spraying a solid pesticide composition with a duster and the like.

본 발명의 농약 입제 조성물은 임의의 방법으로 육묘 상자에 시용할 수 있다. 예컨대 상기에서 말한 상토와의 혼화 외에, 살포기를 이용할 수도 있다. The agrochemical granular composition of this invention can be applied to a seedling box by arbitrary methods. For example, in addition to the above-mentioned mixing with the top soil, a spreader may be used.

본 발명 방법에서 사용할 수 있는 육묘 상자는, 벼의 육묘 상자, 원예 작물(야채, 과수, 화훼)의 셀 트레이, 플라스틱 용기를 들 수 있다. The seedling box that can be used in the method of the present invention includes a rice seedling box, a cell tray for horticultural crops (vegetables, fruit trees, flowers), and a plastic container.

본 발명 방법에서 고형 농약 조성물을 벼 육묘 상자에 시용할 때의 시용량(施用量)은, 육묘 상자 1개당 통상 10∼200 g, 바람직하게는 50∼100 g이다. 미노루 포트 시스템 전용 육묘 상자 448 구멍(미노루산교가부시키가이샤 제조) 등의 플라스틱 용기 시용의 경우, 용기당 통상 33∼66 g(10 a 당 1∼2 kg)이다. In the method of the present invention, when the solid pesticide composition is applied to a rice seedling box, the application amount is usually 10 to 200 g, preferably 50 to 100 g per one seedling box. In the case of application in plastic containers such as the seedling box 448 holes for the Minoru pot system (manufactured by Minoru Sangyo Co., Ltd.), it is usually 33 to 66 g per container (1 to 2 kg per 10 a).

본 발명의 벼 육묘 상자 시용의 농약 입제 조성물은, 농약의 제제화에 있어서 통상 이용되는 조립법에 의해서 얻을 수 있다. 예컨대, 농약 활성 성분, 알킬나프탈렌술폰산 유도체, 알파화 전분, 스멕타이트 광물, 필요에 따라 계면활성제, 수용성 결합제, 용제, 보조제, 증량제 등을 첨가하고, 버티컬 그래뉼레이터(가부시키가이샤파우렉 제조의 상품명)로 혼합 분쇄한 후, 물을 가하여 혼련하고, 압출 조립기를 이용하여 조립한 후, 유동층 건조기로 건조하고, 정립(整粒)하여 조제한다. 또한, 분체 혼합물에 물을 가하면서 전동(轉動) 조립기로 조립하고, 건조, 정립하여도 좋고, 분체 혼합물을 유동시키면서 결합제, 수용액 혹은 유효 성분 등을 스프레이하여 조립하는 유동층 조립기에 의해서도 제조할 수 있다. The agrochemical granular composition for the application of the rice seedling box of this invention can be obtained with the granulation method normally used in formulation of an agrochemical. For example, agrochemical active ingredient, alkylnaphthalenesulfonic acid derivative, pregelatinized starch, smectite mineral, surfactant, water-soluble binder, solvent, adjuvant, extender, etc. are added as necessary, and vertical granulator (trade name manufactured by Paurek Corporation) After mixing and pulverizing with a furnace, water is added and kneaded, granulated using an extrusion granulator, dried with a fluidized bed dryer, and granulated to prepare. In addition, granulation with an electric granulator while adding water to the powder mixture, drying and sizing may be performed, or a fluidized bed granulator can be produced by spraying a binder, aqueous solution or active ingredient while the powder mixture is flowing. .

또한, 본 발명의 벼 육묘 상자 시용 입상물이 취할 수 있는 제형으로서는, 입제, 과립, 정제 등 분말형 이외의 고형 제제이면, 하등 제한을 받지 않는다. In addition, the dosage form that can be taken by the granular material for application in a rice seedling box of the present invention is not limited in any way as long as it is a solid preparation other than powder form such as granules, granules, and tablets.

실시예Example

이어서, 본 발명을 제조예, 실시예, 비교예 및 시험예에 의해 더욱 자세히 설명하지만, 본 발명은 이들에 한정되는 것은 아니다. Next, the present invention will be described in more detail by way of Preparation Examples, Examples, Comparative Examples and Test Examples, but the present invention is not limited thereto.

본 실시예에서 사용한 물질 중, 특별히 설명이 필요한 것을 이하에 기재한다. Among the substances used in this example, those requiring special explanation are described below.

이소티아닐은 공지된 화합물이며, 예컨대 국제공개 제99/024413호 팜플렛에 기재된 방법으로 제조할 수 있다. Isothianil is a known compound, and it can be prepared, for example, by the method described in International Publication No. 99/024413 pamphlet.

펜플루펜은 공지된 화합물이며, 예컨대 국제공개 제2003/010149호 팜플렛에 기재된 방법으로 제조할 수 있다. Fenflufen is a known compound, for example, it can be prepared by the method described in the pamphlet of International Publication No. 2003/010149.

테트라닐리프롤은 공지된 화합물이며, 예컨대 국제공개 제2011/157664호 팜플렛에 기재된 방법으로 제조할 수 있다. Tetraniliprole is a known compound, and can be prepared, for example, by the method described in International Publication No. 2011/157664 pamphlet.

알킬나프탈렌술폰산 유도체로서, MorwetD425(악조노벨사 제조), TERSPERSE2020(한츠만사 제조), 아그로서프 WG-2300(다케모토유지가부시키가이샤 제조) 등을 들 수 있다. Examples of the alkylnaphthalenesulfonic acid derivative include MorwetD425 (manufactured by Akzo Nobel), TERSPERSE2020 (manufactured by Hanzman Corporation), and Agrosurf WG-2300 (manufactured by Takemoto Yuji Co., Ltd.).

알파화 전분으로서는, 예컨대 아미콜 HF, 아미콜 C, 아미콜 KF, 아미콜 HG-N, 아미콜 BJ-2, 아미콜 W, starch MH-A, 아미콜 A, 아미콜 FW(니치덴가가쿠가부시키가이샤 제조), 일식 알스터, 일식 알스터 H, 일식 왁시-α(닛폰쇼쿠힝가코가부시키가이샤 제조), 콘αY, 콘αS-1, 공업용 타피오카α, 공업용 타피오카αTP-2, 소맥 전분 αWA-105(산와덴푼고교가부시키가이샤 제조), 아밀록스 No. 1, 아밀록스 No. 1A(닛폰콘스타치가부시키가이샤 제조) 등을 들 수 있다. As the pregelatinized starch, for example, Amicol HF, Amicol C, Amicol KF, Amicol HG-N, Amicol BJ-2, Amicol W, starch MH-A, Amicol A, Amicol FW (Nichideng Chemical) Co., Ltd.), Japanese Alster, Japanese Alster H, Japanese Waxy-α (manufactured by Nippon Shoku Hinga Co., Ltd.), Corn αY, Corn αS-1, Industrial Tapioca α, Industrial Tapioca αTP-2, Wheat starch αWA-105 (manufactured by Sanwa Denpun Kogyo Co., Ltd.), Amilox No. 1, Amilox No. 1A (made by Nippon Cornstarch Co., Ltd.) etc. are mentioned.

스멕타이트 광물로서는, 적합하게는 몬모릴로나이트를 들 수 있으며, 예컨대 벤토나이트 후지, 벤토나이트 호타카, 벤토나이트 아카기, 벤토나이트 묘기, 수퍼클레이(호쥰가부시키가이샤 제조), 쿠니겔 V1, 쿠니겔 V2, 쿠니겔 VA, 쿠니본드(쿠니미네고교가부시키가이샤 제조), 간사이 벤토나이트(가네산고교가부시키가이샤 제조) 등의 벤토나이트를 들 수 있다. Suitable smectite minerals include montmorillonite, for example, bentonite fuji, bentonite hotaka, bentonite akagi, bentonite myogi, super clay (manufactured by Hojun Corporation), Kunigel V1, Kunigel V2, Kunigel VA, Bentonite, such as Kunibond (made by Kunimine Kogyo Co., Ltd.) and Kansai bentonite (made by Kanesan Kogyo Co., Ltd.), is mentioned.

표 1에 기재된 양의 고체 성분을 만능 혼합 교반기(5DM-L-03-r; DALTON CORPORATION)를 이용하여 혼합하고, 거기에 액체 가용 성분을 최적량의 물(혼합물에 대하여 13.5% 상당)에 가용 후 첨가하고, 또한 2분간 혼합·혼련한 후 조립기(멀티그란 MG-55-2; DALTON CORPORATION 제조)를 이용하여 메쉬 직경 1.0 mm의 스크린으로부터 압출 조립하고, 건조기(FD-LAB-1; POWREX CORPORATION 제조)에 의해 조립물을 80℃에서 건조시켰다. 마지막으로, 1.4 mm 및 0.5 mm 메쉬 사이즈의 체로 체질하여, 본 발명의 농약 입제 조성물 및 비교예 농약 입제 조성물을 얻었다. The solid components in the amounts shown in Table 1 are mixed using a universal mixing stirrer (5DM-L-03-r; DALTON CORPORATION), and the liquid soluble components therein are dissolved in an optimal amount of water (equivalent to 13.5% of the mixture) After adding and mixing and kneading for 2 minutes, extrusion granulation from a screen having a mesh diameter of 1.0 mm using a granulator (Multigran MG-55-2; manufactured by DALTON CORPORATION), and a dryer (FD-LAB-1; POWREX CORPORATION) production), the granulated product was dried at 80°C. Finally, it was sieved with a sieve of 1.4 mm and 0.5 mm mesh size to obtain a pesticide granular composition of the present invention and a comparative pesticide granular composition.

성분ingredient 실시예 1Example 1 실시예 2Example 2 실시예 3Example 3 이소티아닐isotianil 2.002.00 2.002.00 2.002.00 펜플루펜fenflufen 2.002.00 2.002.00 2.002.00 테트라닐리프롤tetraniliprol 1.501.50 1.501.50 1.501.50 알파화 전분pregelatinized starch 2.002.00 2.002.00 2.002.00 알킬나프탈렌술폰산 포르말린 축합물 나트륨염Alkylnaphthalenesulfonic acid formalin condensate sodium salt 0.50.5 0.250.25 00 카르복시메틸셀룰로오스 나트륨염Carboxymethylcellulose sodium salt 1.001.00 1.001.00 1.001.00 폴리옥시알킬렌 알릴페닐에테르 설페이트 나트륨염 Polyoxyalkylene Allylphenylether Sulfate Sodium Salt 2.002.00 2.002.00 2.002.00 디알킬술포숙신산 에스테르염dialkylsulfosuccinic acid ester salt 0.030.03 0.030.03 0.030.03 스멕타이트 광물smectite mineral 15.0015.00 15.0015.00 15.0015.00 시트르산 무수화물citric acid anhydride 0.300.30 0.300.30 0.300.30 화이트 카본white carbon 1.141.14 1.141.14 1.141.14 클레이clay 72.5372.53 72.7872.78 73.0373.03

수도(水稻)의 파종 시 복토 전처리에 의한 벼에 대한 생육 시험 Growth test on rice by pretreatment with soil for sowing of water supply

소형 수도 육묘 상자(통상의 육묘 상자 30 cm×60 cm의 약 12분의 1의 크기)를 이용하여, 파종 시 복토 전에 공시(供試) 입제 조성물을 8.3 g/육묘 상자의 비율로 처리하고, 마른 벼씨(품종: 고시히카리)를 12.5 g 파종했다. 육묘기(종일 28℃)로 66시간 발아시킨 후, 비닐하우스 내의 온상 매트(20℃)로 육묘를 행했다. 21일간 육묘 후, 벼(처리구)의 뿌리 인장 강도를 측정했다. 처리구의 뿌리 인장 강도와 무처리구의 뿌리 인장 강도를 수학식 1에 의해 대비하여 생육률(%)을 산출하고, 하기의 판정 기준에 따라 생육 상황을 평가했다. Using a small water seedling box (about 1/12 the size of a normal seedling box 30 cm × 60 cm), the blank granular composition is treated at a ratio of 8.3 g / seedling box before planting at the time of sowing, 12.5 g of dried rice seeds (variety: Koshihikari) were sown. After making it germinate for 66 hours in the seedling stage (28 degreeC all day), seedling was performed with the hotbed mat (20 degreeC) in a plastic house. After seedling for 21 days, the root tensile strength of rice (treated group) was measured. The root tensile strength of the treated group and the root tensile strength of the untreated group were compared by Equation 1 to calculate the growth rate (%), and the growth status was evaluated according to the following criteria.

[수식 1] [Formula 1]

생육률 = (농업 입제 처리구의 뿌리 인장 강도[N/m2])/(무처리구의 뿌리 인장 강도[N/m2])Growth rate = (root tensile strength [N/m 2 ])/(root tensile strength of untreated group [N/m 2 ])

<<생육 상황의 판정 기준>> <<judgment standard of the growth situation>>

Figure pct00001
Figure pct00001

농약 입제 조성물(표 1)Agrochemical granular composition (Table 1) 생육률(%)Growth rate (%) 생육률 판정Growth rate determination 실시예 1Example 1 103.4%103.4% ---- 실시예 2Example 2 94.6%94.6% -- 비교예 1Comparative Example 1 77.0%77.0% ++

상기 벼에 대한 생육 시험의 결과로부터, 본원 발명의 농약 입제 조성물은 우수한 약해 경감 효과를 갖는 것이 실증되었다. It was demonstrated from the result of the growth test with respect to the said rice that the agricultural chemical granular composition of this invention has the outstanding weak damage alleviation effect.

Claims (6)

농약 활성 성분, 알킬나프탈렌술폰산 유도체, 알파화 전분, 스멕타이트 광물을 함유하는 것을 특징으로 하는 벼 육묘 상자 시용의 농약 입제 조성물. Agrochemical granular composition for rice seedling box application, characterized by containing an agrochemical active ingredient, an alkylnaphthalenesulfonic acid derivative, a pregelatinized starch, and a smectite mineral. 제1항에 있어서, 농약 활성 성분의 함유 비율이 1∼30 중량%인 농약 입제 조성물. The agrochemical granular composition according to claim 1, wherein the content of the agrochemical active ingredient is 1 to 30% by weight. 제1항 또는 제2항에 있어서, 알킬나프탈렌술폰산 유도체의 함유 비율이 0.1∼2.0 중량%인 농약 입제 조성물. The agrochemical granular composition according to claim 1 or 2, wherein the content of the alkylnaphthalenesulfonic acid derivative is 0.1 to 2.0% by weight. 제1항 내지 제3항 중 어느 한 항에 있어서, 알파화 전분의 함유 비율이 0.1∼10 중량%인 농약 입제 조성물. The agrochemical granular composition according to any one of claims 1 to 3, wherein the content of the pregelatinized starch is 0.1 to 10% by weight. 제1항 내지 제4항 중 어느 한 항에 있어서, 스멕타이트 광물이 벤토나이트인 농약 입제 조성물. The agrochemical granular composition according to any one of claims 1 to 4, wherein the smectite mineral is bentonite. 제1항 내지 제5항 중 어느 한 항에 있어서, 스멕타이트 광물의 함유 비율이 1∼50 중량%인 농약 입제 조성물. The agrochemical granular composition according to any one of claims 1 to 5, wherein the content of the smectite mineral is 1 to 50% by weight.
KR1020227028149A 2020-01-14 2021-01-13 Agrochemical granular composition for rice seedling box application with reduced damage KR20220127904A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2020-003700 2020-01-14
JP2020003700 2020-01-14
PCT/JP2021/000739 WO2021145316A1 (en) 2020-01-14 2021-01-13 Granular agricultural chemical composition for rice seedling raising box with which harmful effects are reduced

Publications (1)

Publication Number Publication Date
KR20220127904A true KR20220127904A (en) 2022-09-20

Family

ID=76863822

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227028149A KR20220127904A (en) 2020-01-14 2021-01-13 Agrochemical granular composition for rice seedling box application with reduced damage

Country Status (5)

Country Link
JP (1) JPWO2021145316A1 (en)
KR (1) KR20220127904A (en)
CN (1) CN115135150A (en)
TW (1) TW202139840A (en)
WO (1) WO2021145316A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009221108A (en) 2008-03-13 2009-10-01 Hokko Chem Ind Co Ltd Granular material applied for rice seedling box
JP2012017271A (en) 2010-07-06 2012-01-26 Du Pont Kk Agrochemical granule composition
JP2012508713A (en) 2008-11-17 2012-04-12 ビーエーエスエフ ソシエタス・ヨーロピア Granule preparation containing starch
JP2012111752A (en) 2010-11-05 2012-06-14 Toho Chem Ind Co Ltd Agrochemical granule in which release controlling has been carried out

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56156201A (en) * 1980-05-06 1981-12-02 Takeda Chem Ind Ltd Agricultural and horticultural germicidal composition
JPS62161702A (en) * 1986-01-09 1987-07-17 Hokko Chem Ind Co Ltd Herbicide for paddy rice plant with reduced chemical madage
US10091999B2 (en) * 2014-02-28 2018-10-09 Kumiai Chemical Industry Co. Agrochemical composition for foliage treatment
JP6542606B2 (en) * 2015-08-18 2019-07-10 クミアイ化学工業株式会社 Pesticide composition and use thereof
KR20180078255A (en) * 2015-10-30 2018-07-09 구미아이 가가쿠 고교 가부시키가이샤 Granular pesticide composition
CA3006260C (en) * 2015-11-30 2022-10-18 Kumiai Chemical Industry Co., Ltd. Agrochemical composition and dispersal method therefor
JP6731245B2 (en) * 2015-12-17 2020-07-29 クミアイ化学工業株式会社 Method for producing fine pesticide composition
JP6942035B2 (en) * 2017-11-30 2021-09-29 北興化学工業株式会社 Stabilized paddy rice seedling box granules

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009221108A (en) 2008-03-13 2009-10-01 Hokko Chem Ind Co Ltd Granular material applied for rice seedling box
JP2012508713A (en) 2008-11-17 2012-04-12 ビーエーエスエフ ソシエタス・ヨーロピア Granule preparation containing starch
JP2012017271A (en) 2010-07-06 2012-01-26 Du Pont Kk Agrochemical granule composition
JP2012111752A (en) 2010-11-05 2012-06-14 Toho Chem Ind Co Ltd Agrochemical granule in which release controlling has been carried out

Also Published As

Publication number Publication date
JPWO2021145316A1 (en) 2021-07-22
CN115135150A (en) 2022-09-30
TW202139840A (en) 2021-11-01
WO2021145316A1 (en) 2021-07-22

Similar Documents

Publication Publication Date Title
CN103140136B (en) Antifungal pyrazoles and their mixture
CN113473860A (en) 1, 3, 4-oxadiazoles and derivatives thereof as novel antifungal agents
CN112638893B (en) Substituted thiophenecarboxamides and analogues as antibacterial agents
CN111683528B (en) Use of pyrazolidinopropyl ethers as nitrification inhibitors
CN111683529B (en) Use of alkoxypyrazoles as nitrification inhibitors
CN114007421A (en) Absorption-promoting ULV formulations
TW201631054A (en) Method for treating rise seed
CN111970925A (en) Aqueous nematicidal compositions comprising dispersants to inhibit crystal growth
KR102475584B1 (en) Solid composition for controlling pests containing cyclaniliprole or a salt thereof
CN111526719B (en) Silylethynyl heteroaryl compounds as nitrification inhibitors
WO2017186543A2 (en) Use of fluopyram and/or bacillus subtilis for controlling fusarium wilt in plants of the musaceae family
KR20240026930A (en) Method for controlling resistant noxious arthropods using heterocyclic compounds and compositions containing them
KR20220127904A (en) Agrochemical granular composition for rice seedling box application with reduced damage
WO2021244951A1 (en) Fungicidal compositions
CN113840533A (en) Active compound combinations
EP3750888A1 (en) Crystalline form a of 1,4-dimethyl-2-[2-(pyridin-3-yl)-2h-indazol-5-yl]-1,2,4-triazolidine-3,5-dione
US20210267194A1 (en) Seed treatment method
KR101801427B1 (en) Copulation disruption agent for sap-sucking pests
CN112714614A (en) Use of the fungicide isopfluazum for controlling ergot and reducing sclerotia in cereals
CN114364663A (en) Substituted thiophenecarboxamides and derivatives thereof as microbiocides
CN112888682A (en) Heteroaryl aminoquinolines and analogs
EP4295683A1 (en) Agrochemical formulations comprising crystalline form a of 4-[(6-chloro-3-pyridylmethyl)(2,2-difluoroethyl)amino]furan-2(5h)-one
RU2790292C2 (en) Silyl-ethinyl-hetaryl compounds as nitrification inhibitors
RU2794262C2 (en) Use of alkoxypyrazoles as nitrification
EP3564225A1 (en) Crystalline form of spiromesifen